<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">101393</article-id>
<article-id pub-id-type="doi">10.7554/eLife.101393</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.101393.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Structural Biology and Molecular Biophysics</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Tom1p ubiquitin ligase structure, interaction with Spt6p, and function in maintaining normal transcript levels and the stability of chromatin in promoters</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8141-3194</contrib-id>
<name>
<surname>Madrigal</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1762-8390</contrib-id>
<name>
<surname>Schubert</surname>
<given-names>Heidi L</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6702-2755</contrib-id>
<name>
<surname>Sdano</surname>
<given-names>Matthew A</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2206-6479</contrib-id>
<name>
<surname>McCullough</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-8226-7412</contrib-id>
<name>
<surname>Connell</surname>
<given-names>Zaily</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8477-2483</contrib-id>
<name>
<surname>Formosa</surname>
<given-names>Tim</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>tim@biochem.utah.edu</email>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6796-7740</contrib-id>
<name>
<surname>Hill</surname>
<given-names>Christopher P</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<email>chris@biochem.utah.edu</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03r0ha626</institution-id><institution>Department of Biochemistry, University of Utah School of Medicine</institution></institution-wrap>, <city>Salt Lake City</city>, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03xez1567</institution-id><institution>Plant Biology Laboratory, Salk Institute for Biological Studies</institution></institution-wrap>, <city>La Jolla</city>, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v7tx966</institution-id><institution>High-Throughput Genomics Core Facility, Huntsman Cancer Institute, University of Utah School of Medicine</institution></institution-wrap>, <city>Salt Lake City</city>, <country>USA</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Dang</surname>
<given-names>Weiwei</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Baylor College of Medicine</institution>
</institution-wrap>
<city>Houston</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Dötsch</surname>
<given-names>Volker</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Goethe University Frankfurt</institution>
</institution-wrap>
<city>Frankfurt am Main</city>
<country>Germany</country>
</aff>
</contrib>
</contrib-group>
<pub-date date-type="original-publication" iso-8601-date="2024-12-02">
<day>02</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP101393</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-08-12">
<day>12</day>
<month>08</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-07-09">
<day>09</day>
<month>07</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.07.08.601072"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Madrigal et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Madrigal et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-101393-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Phosphorylation-dependent binding of the <italic>S. cerevisiae</italic> Spt6p tSH2 domain (Spt6p<sup>tSH2</sup>) to the Rbp1p subunit of RNA polymerase II supports efficient transcription. Here, we report that Spt6p<sup>tSH2</sup> also binds the HECT-family E3 ubiquitin ligase Tom1p, a homolog of human HUWE1. Tom1p/HUWE1 have been implicated in targeting many small basic proteins for degradation, including excess ribosomal subunits and histones, although the mechanism of substrate recognition is not known. Our cryo-EM data revealed that Tom1p can adopt a compact α-solenoidal “basket” similar to the previously described structure of HUWE1, with the central cavity partially occupied by a disordered acidic domain. Sub-regions of this acidic domain supported binding to Spt6p or histones/nucleosomes <italic>in vitro</italic>, and the histone-binding region was important for Tom1p function <italic>in vivo</italic>. We also visualized Tom1p in more extended forms, and speculate that transitions among these forms could be important for substrate selection and ubiquitylation. Genomic analyses provided additional support for the previously observed role for Tom1p in maintaining ribosomal protein pools, and also demonstrated a role in maintaining chromatin structure near genes. This suggests that the interaction with Spt6p<sup>tSH2</sup> affects substrate specificity by anchoring Tom1p to localized environments where histone ubiquitylation alters chromatin architecture.</p>
</abstract>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Misnumbered references to the first three supplemental figures have been corrected.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Spt6p is a multifunctional component of the RNA polymerase II (RNAPII) elongation complex (<xref ref-type="bibr" rid="c64">Vos et al. 2018</xref>). A region within the inherently disordered N-terminal domain of Spt6p (<xref rid="fig1" ref-type="fig">Figure 1A</xref>) binds to histones, nucleosomes, and the essential transcription factor Spn1p (<xref ref-type="bibr" rid="c12">Diebold et al. 2010</xref>, <xref ref-type="bibr" rid="c38">McDonald et al. 2010</xref>), the central core domain has been shown to modulate transcription and to contact several elongation complex subunits as well as the emerging transcript (<xref ref-type="bibr" rid="c16">Endoh et al. 2004</xref>, <xref ref-type="bibr" rid="c5">Ardehali et al. 2009</xref>, <xref ref-type="bibr" rid="c64">Vos et al. 2018</xref>, <xref ref-type="bibr" rid="c44">Narain et al. 2021</xref>, <xref ref-type="bibr" rid="c70">Zumer et al. 2021</xref>), and the C-terminal tandem Src-homology 2 (tSH2) domain assists in the coordination of several transcription-associated activities through direct binding to the Rpb1p subunit of RNAPII (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>, <xref ref-type="bibr" rid="c10">Connell et al. 2022</xref>) in cooperation with the Cdc73p subunit of the Paf1 Complex (<xref ref-type="bibr" rid="c14">Ellison et al. 2023</xref>). The Spt6p tSH2 domain (Spt6p<sup>tSH2</sup>) comprises the only known SH2 motifs in the yeast <italic>Saccharomyces cerevisiae</italic>, and it binds directly to a phosphorylated linker region of Rpb1p between its globular catalytic core and the extended heptad repeats of its C-terminal domain <xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>. This interaction is activated by the Bur1p kinase (<xref ref-type="bibr" rid="c8">Chun et al. 2019</xref>), apparently as an early event during the transition between the pre-initiation and elongation phases of transcription, with this interaction contributing to coordination of the dynamic responses of RNAPII to variable local circumstances (<xref ref-type="bibr" rid="c10">Connell et al. 2022</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Tom1p is a phosphosphorylation-dependent binding partner of Spt6<sup>tSH2</sup></title>
<p><bold>A)</bold> Domain structures of Tom1p, Spt6p, and Rpb1p with 3D structures of the core RNAPII elongation complex (6GMH, <xref ref-type="bibr" rid="c64">Vos et al. 2018</xref>) and the tSH2:Rpb1p linker complex (5VKO; <xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>). The two phosphorylation-dependent binding pockets on Spt6p<sup>tSH2</sup> are shown with phosphates colored red. Arrows indicate interactions of Tom1p, Spt6p and Rpb1p. Domains of Tom1p described in subsequent figures are named.</p><p><bold>B)</bold> Yeast strain 7382-3-4 was transformed with vector (Streptavidin-FLAG alone) or plasmid pMS14 (Streptavidin-FLAG-Spt6p<sup>tSH2</sup>), and whole cell lysates were subjected to tandem affinity purification. Proteins that copurified with the Spt6-tSH2 domain were visualized by Coomassie Blue stained SDS-PAGE (Protein) or by detection with purified GST or GST-Spt6p<sup>tSH2</sup> and anti-GST antibodies (Far-western) after transfer to nitrocellulose. Mass spectroscopy was performed on bands excised from the gel after treatment with trypsin, revealing the identities of the proteins indicated.</p><p><bold>C)</bold> Purified Tom1p (Tom1p-Protein A after Protein A removal) was treated with phosphatase (CIP) as indicated. Parallel SDS-PAGE replicas were stained with Coomassie Blue (Protein) or transferred to nitrocellulose and probed with Spt6p<sup>tSH2</sup> (Far-western). Three repeats were performed with three separate samples, and binding was quantified with each sample normalized to the value obtained without CIP. Overall, phosphatase reduced binding to 18% of the untreated values (P = 4 x 10<sup>-6</sup>).</p><p><bold>D)</bold> As in panel C, purified Tom1p was subjected to SDS-PAGE with or without phosphatase (CIP) treatment and probed with WT GST-Spt6p<sup>tSH2</sup> or variants with mutations in one or both of the binding pockets, see panel A: -R indicates an R1282H mutation in the …TPY… binding pocket, -KK indicates a double K1355A, K1435A mutation in the …FSP… binding pocket, and -R,KK indicates all three mutations as described previously (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>). Results from multiple independent measurements were normalized to the average value for WT Spt6-tSH2 with the average and standard deviation shown (t tests yielded P &lt; 0.01 = **, &lt; 0.001 = ***, &lt; 0.0001 = ****).</p></caption>
<graphic xlink:href="601072v2_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Herein, we report that in addition to supporting communication among factors associated with RNAPII transcription, the Spt6p<sup>tSH2</sup> domain also binds directly to the E3 ubiquitin ligase Tom1p. Tom1p is a large, 374 kDa member of a broadly conserved family of HUWE1 factors (also called Mule, Lasu, Ureb1, Arf-BP1, HectH9/E3<sup>Histone</sup>, Ptr1, Upl1, or Eel-1; <xref ref-type="bibr" rid="c23">Hall et al. 2007</xref>, <xref ref-type="bibr" rid="c35">Marin 2018</xref>). This family is characterized by a large N-terminal domain attached to a smaller C-terminal HECT domain (<underline>H</underline>omologous to <underline>E</underline>6-AP <underline>C</underline>arboxyl <underline>T</underline>erminus) that provides ubiquitin ligase activity (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). Altered HUWE1 function is associated with intellectual disabilities (<xref ref-type="bibr" rid="c19">Froyen et al. 2008</xref>, <xref ref-type="bibr" rid="c18">Froyen et al. 2012</xref>, <xref ref-type="bibr" rid="c30">Isrie et al. 2013</xref>), several forms of cancer (<xref ref-type="bibr" rid="c29">Inoue et al. 2013</xref>, <xref ref-type="bibr" rid="c58">Su et al. 2019</xref>), dysregulation of responses to general stress and DNA damage (<xref ref-type="bibr" rid="c24">Herold et al. 2008</xref>, <xref ref-type="bibr" rid="c61">Thompson et al. 2014</xref>, <xref ref-type="bibr" rid="c6">Atsumi et al. 2015</xref>, <xref ref-type="bibr" rid="c3">Amici et al. 2022</xref>), and aberrant regulation of transcription elongation and transcript processing (<xref ref-type="bibr" rid="c69">Yang et al. 2020</xref>, <xref ref-type="bibr" rid="c17">Endres et al. 2021</xref>, <xref ref-type="bibr" rid="c56">Solvie et al. 2022</xref>).</p>
<p>Tom1p has also been implicated in a broad range of processes in yeast, including maintenance of nuclear organization (<xref ref-type="bibr" rid="c62">Utsugi et al. 1999</xref>), cell cycle regulation (<xref ref-type="bibr" rid="c23">Hall et al. 2007</xref>, <xref ref-type="bibr" rid="c34">Kim et al. 2012</xref>, <xref ref-type="bibr" rid="c34">Kim et al. 2012</xref>, <xref ref-type="bibr" rid="c43">Nakatsukasa et al. 2018</xref>), ribosomal assembly and quality control (<xref ref-type="bibr" rid="c60">Tabb et al. 2001</xref>, <xref ref-type="bibr" rid="c59">Sung et al. 2016</xref>, <xref ref-type="bibr" rid="c11">Defenouillere et al. 2017</xref>, <xref ref-type="bibr" rid="c47">Pillet et al. 2022</xref>), mRNA export (<xref ref-type="bibr" rid="c13">Duncan et al. 2000</xref>, <xref ref-type="bibr" rid="c4">Andoh et al. 2004</xref>, <xref ref-type="bibr" rid="c27">Iglesias et al. 2010</xref>), turnover of free histones (<xref ref-type="bibr" rid="c54">Singh et al. 2009</xref>), regulation of transcription (<xref ref-type="bibr" rid="c51">Saleh et al. 1998</xref>), and the DNA damage response (<xref ref-type="bibr" rid="c65">Wang et al. 2017</xref>). A potential unifying theme for these diverse roles is that many of the substrates of Tom1p/HUWE1 are subunits of large complexes, suggesting a role in turning over unincorporated or defective components (<xref ref-type="bibr" rid="c59">Sung et al. 2016</xref>, <xref ref-type="bibr" rid="c68">Xu et al. 2016</xref>). Both Tom1p in yeast and HUWE1 in humans have recently been reported to have E4 ubiquitin ligase activity in addition to E3 activity, suggesting a role in enhancing the polyubiquitylation efficacy of other E3 enzymes (<xref ref-type="bibr" rid="c26">Hwang et al. 2010</xref>, <xref ref-type="bibr" rid="c28">Ilia et al. 2022</xref>, <xref ref-type="bibr" rid="c40">Mengying et al. 2023</xref>). It has been proposed that the large N-terminal domain of Tom1p/HUWE1 promotes substrate recognition (<xref ref-type="bibr" rid="c22">Grabarczyk et al. 2021</xref>, <xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>), but it remains unclear how diverse substrates are recognized by this domain or how the ubiquitylation activity is restricted to appropriate contexts.</p>
<p>In this study, we report finding a direct phosphorylation-dependent physical interaction between Tom1p and Spt6p. Mutational analysis showed that binding requires the same phosphate-binding pockets of Spt6p<sup>tSH2</sup> that are used to bind the Rpb1p linker. The bound region maps to a conserved acidic domain of Tom1p, a separate portion of which is also important for binding histones and nucleosomes, which are likely to be substrates of Tom1p-mediated ubiquitylation.</p>
<p>Genomic studies supported a pattern of localization of Tom1p that correlates with transcription units and suggested that it has a role in maintaining patterns of nucleosome occupancy that are characteristic of promoters and gene bodies. We determined cryo-EM structures of Tom1p to reveal a helical repeat solenoid architecture for the 2,888 residues preceding the C-terminal HECT domain and an overall architecture that resembles the published structures of HUWE1 but with a larger fraction of ordered residues. In addition to the compact ring/solenoid structure (3.07 Å resolution), we also determined “intermediate” (7.79 Å), and “open” (7.10 Å) conformations that may be important for function. The conserved acidic domain was unstructured, but its ends mapped to an internal face of the solenoid, suggesting that this domain partially occupies the central basket region. An attractive hypothesis is that part of the acidic domain participates in substrate recognition or cofactor recruitment, while surfaces of the solenoid and/or protruding domains also contribute to association with substrate and/or ubiquitin, providing access of substrates to the HECT domain for catalysis.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Spt6p<sup>tSH2</sup> binds directly to Tom1p</title>
<p>We previously used targeted proteolysis, far-western blotting, and crystallography to characterize the interaction between the Spt6p<sup>tSH2</sup> domain and a linker region in Rpb1p (<xref rid="fig1" ref-type="fig">Figure 1A</xref>; <xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>), which subsequently guided analysis and interpretation of RNAPII elongation complex cryo-EM structures (<xref ref-type="bibr" rid="c64">Vos et al. 2018</xref>). To ask whether other factors bind Spt6p<sup>tSH2</sup>, we expressed this domain fused to dual streptavidin and FLAG affinity tags in yeast cells and purified it from whole cell lysates under mild conditions. As expected, multiple subunits of the RNAPII complex copurified with the tagged Spt6p<sup>tSH2</sup> domain, and a far-western blot of these factors probed with a purified Spt6p<sup>tSH2</sup>-GST fusion protein confirmed a direct interaction with Rpb1p (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). A single additional factor was also observed to copurify with Spt6p<sup>tSH2</sup> and to bind the Spt6p<sup>tSH2</sup>-GST probe in the far western blot. Mass spectrometry identified this factor as the 374 kDa Tom1p protein.</p>
<p>To confirm this identification, we replaced the <italic>TOM1</italic> promoter with the inducible <italic>GAL1</italic> promoter at the endogenous genomic locus, fused a Protein A tag at the C-terminus of the reading frame, then used this tag to purify overexpressed Tom1p from yeast cells. Following removal of the tag with PreScission protease, the purified protein (which retained a 14-residue C-terminal scar with the sequence RRIPGLINLEVLFQ) also bound the Spt6p<sup>tSH2</sup>-GST fusion in a far-western assay, thereby validating the results from the affinity copurification experiment (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). Binding was substantially reduced upon treatment with phosphatase or when the phosphate-binding pockets in Spt6p<sup>tSH2</sup> were mutated (<xref rid="fig1" ref-type="fig">Figure 1C</xref>, D). The primary direct targets for Spt6p<sup>tSH2</sup> binding in whole cell lysates therefore appeared to be RNAPII-Rpb1p and Tom1p, and these interactions had similar requirements for phosphorylation of the binding sites on Rpb1p or Tom1p and the integrity of the Spt6p<sup>tSH2</sup> pockets that bind Rpb1p peptide phosphoryl groups (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>).</p>
</sec>
<sec id="s2b">
<title>The conserved central acidic domain of Tom1p contains the Spt6p<sup>tSH2</sup> binding site</title>
<p>Partial proteolysis of purified Tom1p with trypsin coupled with far-western blotting localized the Spt6p<sup>tSH2</sup> binding site to an ∼60 kDa trypsin-resistant fragment (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). The majority of unique peptides identified from this band by mass spectrometry clustered in a region adjacent to the large, conserved acidic domain found in all members of the HUWE1 family, which would be expected to be resistant to trypsin (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). We therefore deleted the 259-residue acidic domain (Tom1p<sup>ΔAD</sup>; lacking E1873-E2131; 38% D, E, 4% K, R, pI 3.0) and found that the resulting protein no longer bound Spt6p<sup>tSH2</sup> in the far-western assay (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). Tom1p<sup>ΔAD</sup> was expressed at the normal level in yeast and the purified protein was well-behaved (<xref rid="fig2" ref-type="fig">Figure 2C</xref>), so deletion of the acidic domain did not destabilize Tom1p but did substantially reduce the affinity for Spt6p<sup>tSH2</sup>. Additional internal deletions of segments of the acidic domain were constructed and tested, localizing the Spt6p<sup>tSH2</sup> binding site to a region of 33 amino acids (<italic>tom1-intΔ11</italic> lacking 2031-2063, <xref rid="fig2" ref-type="fig">Figure 2C</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Spt6p<sup>tSH2</sup> binding maps to the acidic domain of Tom1p</title>
<p><bold>A)</bold> Purified Tom1p was incubated with trypsin. Aliquots removed at the indicated times were visualized by SDS-PAGE followed by Coomassie Blue staining (left) or far-western probing with GST-Spt6p<sup>tSH2</sup>.</p><p><bold>B)</bold> The 60 kD band indicated with an arrow in (A) was excised and subjected to complete digestion with trypsin followed by mass spectrometry. The locations of peptides identified are shown in panel B. The inferred tSH2 binding site (bracket) starts with the first peptide of the most significant cluster of peptides and extends about 60 kDa, including the acidic domain which contains few cleavage sites for trypsin.</p><p><bold>C)</bold> Markerless in-frame deletions were constructed to remove the entire acidic domain (<italic>intΔAD</italic>) or subregions within this domain at the endogenous <italic>TOM1</italic> locus. Whole cell lysates were prepared from log-phase cultures and subjected to SDS-PAGE followed by detection with antibodies against Tom1p (middle panel) or Spt6p<sup>tSH2</sup>-GST fusion protein (bottom panel). The antisera cross-reacted with an unidentified protein of about 250 kDa (asterisk) which was unrelated to Tom1p as it was retained in a strain lacking the entire <italic>TOM1</italic> gene (<italic>tom1-Δ0</italic>).</p></caption>
<graphic xlink:href="601072v2_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2c">
<title>The acidic domain comprises separable regions required for individual Tom1p functions</title>
<p>Deletion of the complete Tom1p reading frame (the <italic>tom1-Δ0</italic> allele) causes tight temperature sensitivity (<xref ref-type="bibr" rid="c62">Utsugi et al. 1999</xref> and <xref rid="fig3" ref-type="fig">Figure 3</xref>). This might result from a general defect in processing misfolded proteins that accumulate at higher temperatures, although some observations challenge this interpretation, including the abrupt onset of the growth defect (growth was normal at 30°C, weak at 33°C, and blocked at 34°C; <xref rid="fig3" ref-type="fig">Figure 3</xref>) and partial suppression of the phenotype by use of a different carbon source (<italic>tom1-Δ0</italic> failed to grow on glucose at 35°C but was less impaired when grown on galactose at the same temperature; <xref rid="fig3" ref-type="fig">Figure 3</xref>). Other phenotypes caused by complete loss of Tom1p included sensitivity to caffeine, formamide, and the DNA-damaging agent phleomycin (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Notably, deletion of just the acidic domain (<italic>tom1-intΔAD</italic>) or the left half of this region (<italic>tom1-intΔ4</italic>) caused a similar spectrum of phenotypes as the full gene deletion, even though these alleles did not strongly alter the level of Tom1p in lysates (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). The N-terminal portion of the acidic domain therefore appears to be essential for the <italic>in vivo</italic> functions of Tom1p that are needed to prevent these phenotypes. Deleting less of this region in <italic>tom1-intΔ5</italic> caused a more moderate growth defect at 34°C (although a more severe defect at higher temperatures), and deletions that removed the right side of the acidic domain displayed no apparent phenotypes in these plate assays. The acidic domain therefore appears to have specific functional regions, parts of the left side of the region may have additive or modular roles, and the loss of the site responsible for the main interaction with Spt6p<sup>tSH2</sup> (<italic>tom1-intΔ10, 11</italic>) did not result in failure of a Tom1p function detectable by these growth assays.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>The Tom1p acidic domain is important for <italic>in vivo</italic> functions</title>
<p>Yeast strains with the mutations shown in <xref rid="fig2" ref-type="fig">Figure 2C</xref> were grown to saturation, washed in water, and 10-fold serial dilutions were placed on the media shown and incubated as indicated. YPAD is yeast extract and peptone supplemented with adenine and 2% dextrose and, as indicated, with 15 mM caffeine, 3% formamide, or 6 µg/mL phleomycin. Gal indicates substitution of the dextrose with galactose.</p></caption>
<graphic xlink:href="601072v2_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2d">
<title>Tom1p binds histones and nucleosomes through the acidic domain</title>
<p>Tom1p has been implicated in the turnover of excess levels of small, basic proteins including ribosomal components (<xref ref-type="bibr" rid="c60">Tabb et al. 2001</xref>, <xref ref-type="bibr" rid="c59">Sung et al. 2016</xref>) and histones (<xref ref-type="bibr" rid="c54">Singh et al. 2009</xref>). Unincorporated individual ribosomal proteins are generally unsuitable for binding assays due to their insolubility, so to test the importance of the acidic domain of Tom1p for binding potential substrates we used EMSA with soluble histone complexes. As shown in <xref rid="fig4" ref-type="fig">Figure 4</xref>, Tom1p formed complexes with H2A-H2B dimers, (H3-H4)<sub>2</sub> tetramers, and also with assembled nucleosomes. Titrations of Tom1p or H2A-H2B gave K<sub>d</sub> values of ∼160-330 nM in this assay (Figure S4). Binding was not observed with Tom1p<sup>ΔAD</sup> but complexes formed normally when just the Spt6p<sup>tSH2</sup> binding site was removed in Tom1p<sup>Δ11</sup> (<xref rid="fig4" ref-type="fig">Figure 4</xref>). Taken together, the results support the conclusion that the acidic domain is important for binding potential substrates like histones, that this is important for Tom1p function <italic>in vivo</italic>, and that the interaction with Spt6p<sup>tSH2</sup> has a role distinct from general substrate recognition.</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>The acidic domain of Tom1p mediates binding to histones and nucleosomes</title>
<p>Versions of Tom1p fused to Protein A were purified as described in Methods, mixed with purified yeast histones alone or after reconstitution into nucleosomes with a 181 bp DNA fragment, then separated by native PAGE (<xref ref-type="bibr" rid="c67">Xin et al. 2009</xref>). Histones and nucleosomes were detected by a fluorescent dye attached to a unique cysteine residue in H3 or H2B, or at the 5’ end of the DNA. Free histones do not migrate uniformly in this gel system, typically forming aggregates in the well or being lost during analysis, so bands indicate the formation of complexes with Tom1p. Nucleosomes retain variable amounts of H2A-H2B dimer, with octamers (nucleosomes) and hexamers (hexasomes) migrating differentially, as indicated. Similar to the results with FACT and Spt6p (<xref ref-type="bibr" rid="c67">Xin et al. 2009</xref>, <xref ref-type="bibr" rid="c36">McCullough et al. 2015</xref>), nucleosomes only formed complexes with Tom1p in the presence of the HMGB family factor Nhp6p.</p></caption>
<graphic xlink:href="601072v2_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2e">
<title>Genomic analysis supports a role for Tom1p in managing chromatin during transcription</title>
<p>Interaction of Tom1p with Spt6p and histones suggests a role in transcription, possibly assisting Spt6p with managing the properties of chromatin as it is dynamically remodeled during promoter activation or transcription elongation. To test this possibility, we measured the effects of deleting <italic>TOM1</italic> on steady-state transcript levels by RNA-seq, the global occupancy of Tom1p by ChIP-seq and the effects of deleting <italic>TOM1</italic> on chromatin structure by MNase-seq.</p>
<p>RNA-seq revealed a significant decrease in the steady-state level of ribosomal protein gene transcripts in cells lacking Tom1p (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). This is consistent with a role for Tom1p in degrading unincorporated ribosomal subunits as previously described (<xref ref-type="bibr" rid="c59">Sung et al. 2016</xref>) as unbalanced expression of any ribosomal protein signals a reduction in the transcription of all genes in this class.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Genomic analysis supports a role for Tom1p in transcription that involves maintaining chromatin architecture in promoters and gene bodies</title>
<p><bold>A)</bold> RNA-seq was performed with WT and matched <italic>tom1-Δ0</italic> strains in triplicate and the log2FC value for mutant/WT was calculated for each gene. Transcript levels from most genes were only modestly affected by loss of Tom1p (7 genes had decreased transcript levels and 16 genes were increased at a threshold of a 2-fold decrease at a false discovery rate below 1%). As a group, transcripts from genes encoding ribosomal protein genes (red stars) were generally decreased, forming a distinct subset (red stars).</p><p><bold>B)</bold> A 12xV5 tag was fused to the C-terminus of the Tom1p ORF at the endogenous locus and anti-V5 antibodies were used to perform ChIP-seq with three independent clones and a matched strain without the tag. ChIP signal relative to input DNA was calculated genome-wide and mapped for each gene normalized to an averaged gene size of 1000 arbitrary units, as well as 200 bp upstream and downstream of each gene. Genes were ordered by their transcript levels determined by RNA-seq using a matched WT strain (<xref ref-type="bibr" rid="c10">Connell et al. 2022</xref> and panel A). The average Tom1p occupancy values are shown for the highest, lowest, and middle transcript level deciles.</p><p><bold>C, D)</bold> MNase-seq was performed in triplicate with independent isolates of WT and <italic>tom1-Δ0</italic> strains, and reads were parsed into groups by the size of the protected DNA fragment. 140-170 bp fragments were classified as nucleosomes, representing ∼36% of all reads, and 90-120 bp fragments were classified as subnucleosomes, representing ∼3.6% of all reads. Protected fragments were mapped to the annotated transcription start site (TSS) of each gene. Genes were placed in deciles by transcript levels as in panel B and the log<sub>2</sub>FC occupancy values shown are relative to nucleosomes (C) and subnucleosomes (D).</p></caption>
<graphic xlink:href="601072v2_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Antisera generated against purified Tom1p were not suitable for ChIP, presumably due to interference from an abundant cross-reacting protein (asterisk, <xref rid="fig2" ref-type="fig">Figure 2C</xref>). Epitope tags fused to either the N-terminus or C-terminus of Tom1p produced the same spectrum of phenotypes as null alleles, suggesting inactivation of key functions of Tom1p (not shown). We therefore used a 12x-V5 tag fused to the C-terminus of Tom1p for the ChIP-seq experiment; while this disrupted its physiological function (consistent with results obtained with other HECT domain proteins like E6AP and Rsp5p; <xref ref-type="bibr" rid="c52">Salvat et al. 2004</xref>, <xref ref-type="bibr" rid="c31">Kamadurai et al. 2009</xref>), it did not alter the steady-state level of Tom1p or its interaction with Spt6, suggesting any Spt6-driven localization should remain intact.</p>
<p>Tom1p-12xV5 occupancy mapped to gene bodies, especially genes with high transcript levels (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). In contrast, occupancy was particularly low over the promoters of these highly expressed genes. An untagged strain gave little signal, so we conclude that Tom1p was associated with highly transcribed gene bodies but was less associated with promoters.</p>
<p>To examine a potential role in maintaining chromatin, we mapped nucleosomal occupancy by paired-end MNase-seq in normal and <italic>tom1-Δ0</italic> strains (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). Once again, we observed stronger effects in the decile of genes with the highest transcript levels, with loss of Tom1p leading to a decrease in nucleosome occupancy relative to a WT strain over promoters, approximately normal occupancy at the +1 nucleosome, and elevated occupancy over gene bodies. This suggests that Tom1p has a role in stabilizing nucleosomal occupancy in promoters and slightly decreasing the occupancy in gene bodies. A similar effect was seen over promoters when we mapped MNase-resistant DNA fragments smaller than those protected by full nucleosomes (“sub-nucleosomal” fragments that could arise from partial nucleosomes or other DNA-binding proteins) (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). In this case, gene bodies were relatively unaffected, but loss of Tom1p caused a universal reduction in protection of promoter regions. Tom1p therefore appears to have a role in maintaining chromatin architecture, especially in the promoters of highly transcribed genes.</p>
<p><italic>TOM1</italic> has been implicated previously in histone turnover (<xref ref-type="bibr" rid="c54">Singh et al. 2009</xref>), but we did not observe a change in the total steady-state level of either soluble or chromatin-bound histone H3 in strains lacking Tom1p (Figure S5). A role in histone turnover may therefore be redundant with other factors or limited to a specific subset of histones, possibly those being displaced near promoters as the result of dynamic processes related to transcriptional regulation.</p>
<p>Collectively, these genomics results are consistent with a role for Tom1p in maintaining normal levels of ribosomal proteins and transcripts. They also show that Tom1p occupancy varies with gene structure, especially for highly transcribed genes, and it may directly affect the stability or turnover of nucleosomes, with differential effects in promoters and gene bodies.</p>
</sec>
<sec id="s2f">
<title>Tom1p Structure Determination</title>
<p>We performed single-particle cryo-EM reconstructions of two Tom1p constructs: full-length Tom1p that contained a 20-residue tag including 12 histidines inserted between residues K1074-D1075 (Tom1p<sup>His</sup>; physiologically active in all phenotype assays) and Tom1p<sup>ΔAD</sup> with the C-terminal Protein A described for intact Tom1p above (<xref rid="fig2" ref-type="fig">Figure 2C</xref>, presumably inactive). These structures were determined at resolutions of 3.97 Å (Tom1p<sup>His</sup>) and 3.07 Å (Tom1p<sup>ΔAD</sup>) for the dominant closed ring conformations (<xref rid="fig6" ref-type="fig">Figure 6B</xref>, 7C, S6). The two maps and structural models were very similar to each other, indicating that neither the internal affinity tag, the absence of the acidic domain, or the presence of a C-terminal Protein A scar induced notable conformational changes. Unless otherwise noted, the higher resolution Tom1p<sup>ΔAD</sup> map was used for descriptions and illustrations herein. As expected, the acidic domain was disordered in the Tom1p<sup>His</sup> structure. 2,792 (85%) of the 3,268 Tom1p residues were modeled into Tom1p<sup>ΔAD</sup>, which corresponds to 96% of the residues in Tom1p<sup>ΔAD</sup> (<xref rid="fig6" ref-type="fig">Figure 6A</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Structure of yeast Tom1p in the closed conformation and comparison with human HUWE1</title>
<p><bold>A)</bold> Alignment of human HUWE1 and Tom1p sequences. Modeled residues indicated with solid bars; disordered regions are striped. Motifs/domains recognized from the sequence or defined in the structure are indicated with color. Tom1p: Head domain (1-436), Neck (437-506), UBA-like domain (1195-1261), HWA(1510-1594), acidic domain (1873-2131), Tower helix (2221-2276), UBM module (2317-2398), HECT N-terminal lobe (2889-3146), HECT C-terminal lobe (3147-3268). Body colored grey. Human HUWE1 WWE domain is not present in Tom1p. Beginning and end points of missing density in Tom1p<sup>ΔAD</sup> structure: 214-235, 1873-2219 (region containing acidic domain), 2276-2316, 2399-2449, 2575-2589.</p><p><bold>B)</bold> Top-down (left) and side (right) views of the 3.07 Å Tom1p<sup>ΔAD</sup> map. Disordered residues of the acid domain are shown as pink coil in random positions. Other disordered regions not depicted. The structure of Tom1p<sup>His</sup> is very similar, with the exception of more poorly resolved density at the UBM domain.</p><p><bold>C)</bold> Top-down view of Tom1pΔAD (grey) aligned with human HUWE1 (tan) (Hunkeler et al. 2001; PDB 7JQ9). The close-up shows a clipped side view of the interior of the basket between the Tower and UBM regions. The ordered residues either side of the disordered acidic domain are shown: Tom1p, magenta, residues 1872, 2220; HUWE1 light pink).</p></caption>
<graphic xlink:href="601072v2_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2g">
<title>Closed Ring Conformation and Comparison with HUWE1</title>
<p>Similar to the published structures of HUWE1 from humans (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>) and the fungus <italic>Nematocida</italic> (<xref ref-type="bibr" rid="c22">Grabarczyk et al. 2021</xref>), Tom1p comprises more than 100 helices in a series of HEAT or ARM-like repeats that extend over the first 2,888 residues in an α-solenoid conformation comprised of Head, Neck, Body that precedes the C-terminal HECT domains (<xref rid="fig6" ref-type="fig">Figure 6</xref>).</p>
<p>The N-terminal 436 residues comprise the Head domain, in which the first 6 helices form three 2-helix repeats, followed by a bundle of loops and helices from residues 153-286, before the helical repeat pattern continues at residue 287 with several ARM repeats. The globular Head is followed by the Neck domain (residues 437-506) comprising one ARM-like repeat followed by a loop (residues 488-506) that extends toward the interior of the solenoid to lie along the surface of the Head domain (Figure S6C). The Neck is followed by the Body domain (residues 507-2,888), which comprises a helical repeat solenoid structure that forms a ring architecture and leads into the C-terminal HECT domain. The first helix of the HECT domain, residues 2889-2906, helps to close the ring by packing between the HECT N- and C-lobes on one side and the Head and Neck domains on the other side. The Head domain largely closes one side of the ring formed by the Body domain to create a basket-shaped structure, while the HECT domain is positioned to one side at the opposite, open face of the basket. This overall structure is conserved in human HUWE1 (<xref rid="fig6" ref-type="fig">Figure 6A</xref>, 6C), although one-to-one structural correspondence of individual residues is not generally apparent outside of the HECT domain. This is consistent with the low (20%) sequence identity for <italic>S. cerevisiae</italic> Tom1p and human HUWE1 residues outside of the HECT domain and higher (53%) identity between their HECT domains.</p>
<p>Several domains, including some with similarity to known protein-interaction modules, are encoded in inter-helical loops that protrude from the Body domain on the rim of the basket structure. Some of these motifs and domains have been identified in the sequence of human HUWE1, although several of them were not visualized in the HUWE1 structure due to disorder (<xref ref-type="bibr" rid="c22">Grabarczyk et al. 2021</xref>). Most of the 1,106 additional residues in the 4,373-residue HUWE1 protein that lack counterparts in Tom1p are disordered in the HUWE1 structure and occur, in about equal parts, as insertions between the solenoid helices or within the protrusions that are conserved in Tom1p.</p>
<p>All of the protruding domains in Tom1p have counterparts in HUWE1. Starting from the N-terminal end, these include a 3-helix bundle (residues 1201-1260) that corresponds to a region of HUWE1 that was classified as a UBA (Ubiquitin Associated) domain on the basis of sequence alignment, although these residues were not visualized in the HUWE1 structure and in Tom1p the third helix adopts the opposite orientation relative to canonical UBA domains. An HWA (HUWE1 Associated) domain is conserved in HUWE1 and Tom1p (residues 1510-1594), although the structurally adjacent 78-residue WWE domain of HUWE1 is replaced by a loop in Tom1p (residues 1404-1427). The Tom1p acidic domain (residues 1873-2131), which is conserved in HUWE1, is found within a larger disordered region (residues 1871-2219), the ends of which are located on the inner face of the solenoid, suggesting that this unstructured component of Tom1p will at least partially occupy the basket (<xref rid="fig6" ref-type="fig">Figure 6B</xref>, 6C). Ordered structure resumes only six residues before the start of the Tower domain (residues 2221-2276), for which the two-helix protrusion of HUWE1 is replaced by a single helical protrusion in Tom1p followed by ∼50 flexible residues and 2 adjacent UBMs (Ubiquitin-Binding Motifs; residues 2317-2398) that substitute for the 3 UBMs observed in HUWE1 (<xref rid="fig6" ref-type="fig">Figure 6A</xref>).</p>
</sec>
<sec id="s2h">
<title>Open conformation</title>
<p>In addition to the closed ring structure, the Tom1p<sup>His</sup> dataset contains particles in “intermediate” and “open” conformations that were reconstructed to resolutions of 7.79 and 7.10 Å, respectively (<xref rid="fig7" ref-type="fig">Figs 7C</xref>, S6C-D). The distinction between closed and open/intermediate conformations is modeled as a rigid body hinging of 30° (open) or 15° (intermediate) centered at a loop (1316-1320) in the middle of the Body domain at the opposite side of the ring from the N-terminal Head and C-terminal HECT domains (<xref rid="fig7" ref-type="fig">Figure 7B</xref>, 7C). The resolution does not allow precise modeling of the change in conformation, but apart from the rigid body rotations, conformational changes appear to be limited to some repacking of the interface between the two halves of the Body domain and modest shift in adjacent helices (<xref rid="fig7" ref-type="fig">Figure 7A</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Tom1p<sup>His</sup> hinging motion</title>
<p><bold>A)</bold> When aligned separately, the N-terminal and C-terminal halves of closed, intermediate, and open conformation Tom1 superimpose closely. Center: Top-down view of the Tom1p<sup>His</sup> closed-conformation model with residues 1-1315 colored dark grey and 1321-3268 colored light gray. Top: same orientation showing the three Tom1p<sup>His</sup> conformation models aligned for residues 1-1315: closed (grey), intermediate, (pink) and opened (turquoise). Bottom: Same orientation, showing the three Tom1p<sup>His</sup> conformation models aligned for residues 1321-3268.</p><p><bold>B)</bold> The N-terminal and C-terminal halves of closed, intermediate, and open conformation Tom1p display a hinging motion Top-down and side views of the three Tom1p<sup>His</sup> conformation models aligned on residues 1-1315. The hinging motion, centered on loop 1316-1320 (green), is <sup>∽</sup> 15° and <sup>∽</sup>30° for the intermediate and open conformations, respectively.</p><p><bold>C)</bold> Same as (B) but showing maps for the three structures.</p></caption>
<graphic xlink:href="601072v2_fig7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Published cryo-EM studies of human HUWE1 indicated the presence of movement towards an open state analogous to that of Tom1p, although density for residues C-terminal to the hinge were not apparent (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>). Mutation of two residues in the Head domain at the solenoid closure interface reduced human HUWE1 E3-ligase activity, suggesting that the closed conformation is important for the catalytic cycle (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>).</p>
</sec>
<sec id="s2i">
<title>The HECT domain adopts a constrained/inactive conformation</title>
<p>The 379-residue HECT domain adopts similar structures and maintains the same intramolecular contacts in the open and closed solenoid structures of Tom1p and in the published structures of human (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>) and <italic>Nematocida</italic> (<xref ref-type="bibr" rid="c22">Grabarczyk et al. 2021</xref>) HUWE1. Overlap of the Tom1p and human HUWE1 HECT domains shows a 1.1 Å RMSD over 256 pairs of Cα atoms. HECT domains comprise two lobes, an N-terminal lobe and a smaller C-terminal lobe that houses the catalytic cysteine residue (C3235 in Tom1p). Multiple HECT domain crystal structures have indicated that the two lobes rotate with respect to each other through the catalytic cycle of binding E2, transthiolation of ubiquitin from E2 to the HECT domain cysteine, and subsequent ubiquitylation of substrate. The N-terminal Head domain makes clearly defined, extensive contacts with the final ARM-like repeat of the Body domain that leads into the first helix of the HECT domain (residues 2289-2904; <xref ref-type="bibr" rid="c32">Kane et al. 2022</xref>). The HECT domain conformation appears to be unaltered in the open or intermediate structures, and we were unable to show substantial HECT domain C-lobe motion relative to the N-lobe, or motion of the HECT domain relative to the neighboring segment of solenoid using 3DVA (Punjani et al. 2021) or the beta version of 3D Flex (Punjani et al. 2023).</p>
<p>The Tom1p HECT conformation closely resembles that of the human apo HECT domains of HUWE1 (PDB ID 3H1D; <xref ref-type="bibr" rid="c45">Pandya et al. 2010</xref>), AREL1 (PDB ID 6JX5; <xref ref-type="bibr" rid="c55">Singh et al. 2019</xref>), and WWP1 (PDB ID 1ND7; <xref ref-type="bibr" rid="c63">Verdecia et al. 2003</xref>), with the HECT catalytic cysteine inaccessible to a bound ubiquitin-charged E2 enzyme (<xref rid="fig8" ref-type="fig">Figure 8A</xref>, 8B, 8C). Simple docking of Tom1p onto a NEDD4L HECT domain complex with a ubiquitin-charged E2; <xref ref-type="bibr" rid="c31">Kamadurai et al. 2009</xref>, PDB ID 3JW0) or onto HECT-Ub structure (HUWE1:Ubq; <xref ref-type="bibr" rid="c42">Nair et al. 2021</xref>, PDB ID 6XZ1) suggests that the Tom1p HECT could undergo a full catalytic cycle within the framework of the closed conformation without major structural adjustment of the N-lobe with respect to the α-solenoid (<xref rid="fig8" ref-type="fig">Figure 8C</xref>, 8D).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>HECT domain comparisons between constructs, conformations, homologs, and catalytic states.</title>
<p><bold>A)</bold> Tom1 HECT domain. Tom1p<sup>ΔAD</sup> HECT domain is shown. Tom1p<sup>His</sup> closed, intermediate, and open conformations are superimposable within experimental error. Catalytic cysteine, yellow.</p><p><bold>B)</bold> Superposition of Tom1p and HUWE1 HECT domains. Tom1p<sup>ΔAD</sup>, gray; human HUWE1, tan (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>; PDB 7MWD), Tom1p HECT crystal structure, green.</p><p><bold>C)</bold> Tom1p (grey) and human Nedd4L HECT domains superimposed on their N-lobes. The Nedd4L HECT structure (lavender) is a complex with a Ub-charged E2 (yellow, green) (PDB 3JW0; <xref ref-type="bibr" rid="c31">Kamadurai et al. 2009</xref>. C-lobes show a relative rotation of 63°.</p><p><bold>D)</bold> Tom1p<sup>ΔAD</sup> (grey) superimposed on N-lobe with human HUWE1 HECT domain (brown) covalently bound to Ub-propargylamine (yellow) (PDB 6XZ1; <xref ref-type="bibr" rid="c42">Nair et al. 2021</xref>). C-lobes show a relative rotation of 167°.</p></caption>
<graphic xlink:href="601072v2_fig8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>Spt6p contacts several subunits of the core RNAPII elongation complex, the emerging transcript, and the surfaces of histones as nucleosomes are transiently disrupted during transcription (<xref ref-type="bibr" rid="c64">Vos et al. 2018</xref>, <xref ref-type="bibr" rid="c70">Zumer et al. 2021</xref>). The C-terminal tSH2 domain of Spt6p binds a phosphorylated linker region of the RNAPII catalytic subunit, Rpb1p, and this contact is important for coordinating the dynamic changes that occur during a transcription cycle, potentially by mediating communication among the multiple functional modules of the RNAPII elongation complex (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>, <xref ref-type="bibr" rid="c10">Connell et al. 2022</xref>). Here, we report an unexpected additional Spt6p<sup>tSH2</sup> ligand, the E3 ubiquitin ligase Tom1p. Similar to the Spt6p<sup>tSH2</sup>-Rpb1p interaction, Tom1p binding was phosphorylation-dependent and mapped to a short peptide within an unstructured region, in this case an acidic domain conserved among known Tom1p/HUWE1 homologs. Genomic analysis supported the previously described role for Tom1p in regulating ribosomal protein turnover but also suggested an unexpected role in transcriptional regulation, possibly through altered histone turnover that affects local chromatin architecture. Our structural analysis revealed a closed solenoidal ring structure and multiple open conformations suggestive of dynamic conformational changes to a spiral shape. These findings provide a foundation for efforts to understand how this conserved family of ubiquitin ligases chooses substrates, how its activity is limited to appropriate circumstances, and how it might modulate chromatin structures important for transcriptional regulation or DNA repair.</p>
<p>The HECT domains of Tom1p/HUWE1 family members are thought to ubquitylate substrates, likely for subsequent degradation by the proteasome, while more N-terminal sequences presumably function in substrate recognition. Our data support a role for the flexible acidic domain in binding small basic proteins like ribosomal proteins and histones, although a simple electrostatic mechanism seems inadequate to produce appropriate specificity. We confirmed that the acidic domain of Tom1p was necessary for binding nucleosomes and histones and for performing its main physiological functions, although deleting distinct parts of the acidic domain produced different, partially additive phenotypes, indicating specific but diffusely distributed functions (<xref rid="fig2" ref-type="fig">Figs 2C</xref>, <xref rid="fig3" ref-type="fig">3</xref>). We therefore propose that the acidic domain is important for substrate recognition, and that the N-terminal region of this domain may have a dispersed, non-specific electrostatic role while the C-terminal portion contributes more to interaction with other factors like Spt6p.</p>
<p>The interaction with Spt6p is not required for Tom1p activity, as indicated by our finding that deletion of the binding site did not cause the growth defects associated with full loss of Tom1p. Interaction with Spt6p is therefore more likely required to optimize some function of Tom1p, possibly by regulating when or where it should be active on a subset of targets. The interaction of Spt6p<sup>tSH2</sup> with Rpb1p has a similarly non-essential but advantageous function (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>, <xref ref-type="bibr" rid="c10">Connell et al. 2022</xref>). In that case, Spt6p<sup>tSH2</sup> appears to collaborate with the Paf1 complex to make a stable contact with the Rpb1p linker (<xref ref-type="bibr" rid="c14">Ellison et al. 2023</xref>), suggesting that the tSH2 binding sites are typically occupied by Rpb1p during elongation. The pattern of Tom1p occupancy (low in promoters, high in gene bodies) suggests it might be tethered to elongation complexes, while the effect of loss of Tom1p on nucleosome occupancy (decreased in promoters, increased in gene bodies) suggests that it might be stabilizing nucleosomes in promoters and destabilizing them in gene bodies. Taken together, these observations suggest that Tom1p associates with Spt6p in promoters before the elongation complex forms and that this spares free histones from degradation, while a looser or different association of Tom1p with the elongation complex enhances its occupancy in gene bodies where it is more prone to promoting histone turnover. Other models are possible and will require further testing.</p>
<p>The 259 residues of the acidic domain of Tom1p lack density in our structural analysis, presumably due to being disordered. One possibility is that this ∼29 kDa domain occupies the solenoidal basket, perhaps extending above the basket rim, and that it retains basic substrate proteins in the central region of the solenoid. It is also possible that the shift from the closed ring to the open spiral form is important for function. Mutations expected to destabilize closure of the ring conformation were reported to compromise E3 ligase activity of human HUWE1 (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>) and similar mutations of <italic>Nematocida</italic> HUWE1 were found to destabilize the protein (<xref ref-type="bibr" rid="c22">Grabarczyk et al. 2021</xref>). It has also been proposed that opening of the ring releases the HECT domain into a more flexible environment that allows its active site to turn towards substrates bound to N-terminal regions of the protein (<xref ref-type="bibr" rid="c25">Hunkeler et al. 2021</xref>) (<xref ref-type="bibr" rid="c22">Grabarczyk et al. 2021</xref>). The functional relevance of the ring vs spiral conformations, and the possibility of functional transition between the two states, is an important topic for future studies.</p>
<p>In summary, this work reveals an unexpected role for Tom1p/HUWE1 family members in maintaining the appropriate pools of partially assembled nucleosomal components in different contexts to maintain differential chromatin architecture in promoters and transcribed regions. One possibility is that the interaction with Spt6p serves to localize Tom1p/HUWE1 to these regions. It is also possible that the Spt6p<sup>tSH2</sup>-Tom1p interaction competes with or modulates the Spt6p<sup>tSH2</sup>-Rpb1p interaction, thereby providing information to this hub to assist in coordinating progression of the elongation complex. The structures provided here will be a basis of future work to investigate these ideas.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<sec id="s4a">
<title>Strains/constructs</title>
<p>Yeast strains (Table S1) were isogenic with the A364a background and were constructed using standard methods. The <italic>tom1-Δ</italic>0 allele was transferred from the standard deletion collection (Research Genetics; <xref ref-type="bibr" rid="c7">Brachmann et al. 1998</xref>) into the A364a background using primers TF1654, TF1655 (Table S2) to construct strain 9731 (Table S1), which was used to construct additional strains in this background using standard genetic methods.</p>
<p>The pCORE cassette (<xref ref-type="bibr" rid="c57">Storici et al. 2001</xref>) was integrated into the <italic>TOM1</italic> locus in the promoter region (primers TF1658, TF1659), after residue K1074 (primers TF2111, TF2112), and after S1943 (primers TF1714, TF1715). These strains were then used to swap the native <italic>TOM1</italic> promoter with the <italic>GAL1</italic> promoter, to integrate tags, and to create various internal deletions of the acidic domain using the primers listed in Table S2.</p>
<p>The promoter region of <italic>TOM1</italic> was replaced with the <italic>GAL1</italic> promoter using the delitto perfetto method (<xref ref-type="bibr" rid="c57">Storici et al. 2001</xref>), then a PreScission site-Protein A sequence was fused in-frame to the C-terminus of the Tom1p ORF (strain 9750, Table S1). A 20-residue encoding SGGGGGGSRHHHHHHHHHHHH was fused in-frame between K1074 and D1075 in a loop region identified in the Tom1p cryo-EM structure, also using the delitto perfetto method (<xref ref-type="bibr" rid="c57">Storici et al. 2001</xref>). Primers for these constructions are listed in Table S2.</p>
</sec>
<sec id="s4b">
<title>Plasmids</title>
<sec id="s4b1">
<title>Strep-FLAG-Spt6p<sup>tSH2</sup> construct</title>
<p>The coding sequence for Spt6p(1223-1451) was amplified from genomic DNA using PCR primers TF0950 and TF0951 (Table S2). The product was digested with Nde1 and BamH1, then ligated with pTF198 (YEp_LEU2_Gal1) digested with the same enzymes to create pTF254 with a FLAG epitope fused to the N-terminus of the Spt6p tSH2 domain. <italic>Kpn1</italic> and <italic>Xho1</italic> sites were introduced between the FLAG epitope and the Spt6p<sup>tSH2</sup> coding sequence using site-directed mutagenesis with primers MS1+/-to create pTF254-KX. A twin-Strep-tag sequence (IBA) flanked by Kpn1 and Xho1 sites was then constructed by annealing primers MS351, MS352 and this was inserted into pTF254-KX to yield pMS14 (CPH3375) expressing an N-terminal streptavidin-FLAG tandem affinity tag (SF-TAP; <xref ref-type="bibr" rid="c20">Gloeckner et al. 2007</xref>) fused to Spt6p<sup>tSH2</sup>, followed by an in-frame C-terminal SV40 nuclear localization signal, under control of the <italic>GAL1</italic> promoter.</p>
</sec>
<sec id="s4b2">
<title>GST-Spt6p<sup>tSH2</sup> construct (WT and -R, -KK, -R,KK)</title>
<p>Plasmids expressing GST-tagged Spt6p were produced by inserting the Spt6p(1223-1451) coding sequence into the pDEST15 vector (Thermo Fisher Scientific). Mutations in the tSH2 domain were introduced using site-directed mutagenesis (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>).</p>
</sec>
</sec>
<sec id="s4c">
<title>Protein expression and purification</title>
<p>All protein purification steps were performed at 4°C, unless otherwise stated.</p>
<sec id="s4c1">
<title>Strep-FLAG-Spt6p<sup>tSH2</sup></title>
<p>Yeast transformed with plasmid pMS14 [SF-Spt6p<sup>(1223-1451)</sup> or pTF198 (empty) were cultured in two liters of synthetic media containing glycerol and lactate in baffled flasks at 30 °C. When the OD<sup>600</sup> reached ∼1, expression was induced by the addition of galactose to 0.55% and incubation was continued overnight. Cells were harvested by centrifugation and lysed under liquid nitrogen using a freezer mill. Subsequent steps were performed at 4°C. Yeast powder was suspended in an equal volume of lysis buffer (100 mM Tris•Cl pH 7.5, 300 mM NaCl, 10% glycerol, 1 mM DTT, 0.1% Tween-20, 1x protease inhibitors [0.5 μg/mL aprotinin, 0.5 μg/mL leupeptin, 0.7 μg/mL pepstatin, 167 μg/mL PMSF], 1x phosphatase inhibitors [2 mM NaVO<sub>4</sub>, 2 mM BGP, 2 mM NaF], 6 μg/mL DNAse I, 2 μg/mL RNAse A) and clarified by centrifugation at 107,000 RCF for 30 minutes. 120 μg avidin was added to the clarified lysate and incubated for 15 minutes to block biotinylated proteins. Lysates were clarified further by ultracentrifugation at 107,000 RCF for 1 hour. The supernatant was applied to 100 μl Strep-Tactin® Superflow resin (IBA) and incubated for 1 hour. The resin was washed with 10 column volumes of wash buffer (50 mM Tris•Cl pH 7.5, 150 mM NaCl, 5% glycerol, 0.1% Tween-20, 1x protease and phosphatase inhibitors, 6 μg/mL DNAse, 2 μg/mL RNAse A) and eluted with buffer containing 2 mM desthiobiotin. The eluate was applied to 50 μl anti-FLAG<sup>®</sup> M2 affinity gel (Sigma-Aldrich) and incubated for 1 hour. The resin was washed 3 times with 100 μl wash buffer and eluted with 150 μl wash buffer containing 200 μg/mL FLAG peptide. Proteins were separated by SDS-PAGE on NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gels (Invitrogen) in MOPS running buffer, and proteins were visualized by staining with Coomassie Blue dye.</p>
</sec>
<sec id="s4c2">
<title>GST-Spt6p<sup>tSH2</sup></title>
<p>GST-Spt6p<sup>tSH2</sup> proteins were expressed and purified as described previously (<xref ref-type="bibr" rid="c9">Close et al. 2011</xref>), except the lysate was applied to glutathione agarose resin (Pierce) and the proteins were not cleaved but instead were eluted with 10 mM glutathione to leave the GST tag intact.</p>
</sec>
<sec id="s4c3">
<title>Tom1p and Tom1p<sup>ΔAD</sup></title>
<p><italic>S. cerevisiae</italic> strains 9750 (intact Tom1p-PrtA) or 10232 (Tom1p<sup>ΔAD</sup>-PrtA) was grown on an orbital shaker in non-baffled flasks in YP media containing glycerol and sodium lactate to saturation at 30 °C, and protein expression was induced overnight via addition of galactose to 0.5% w/v. Cells were harvested by centrifugation at 5,000 RCF, lysed under liquid nitrogen using a freezer mill, and stored at -80 °C. 40 g pulverized yeast lysate were added to 150 mL total lysis buffer (containing 50 mM Tris•Cl pH 7.5, 500 mM NaCl, 10% glycerol, 0.1% Tween-20, 1 mM DTT). 167 ug/mL PMSF, 0.7 ug/mL aprotinin, 0.7 ug/mL leupeptin, and 0.9 ug/mL pepstatin as protease inhibitors, plus 2 mM BGP and 2 mM NaF as phosphatase inhibitors were added to the initial lysate solution. Cell lysate was stirred vigorously at 4 °C for 10 minutes, vortexed briefly for 1 second, and clarified via centrifugation at 18,000 RCFfor 35 minutes.</p>
<p>Clarified lysate was added to 2.3 mL of a 50% IgG Sepharose 6 Fast Flow resin (GE Healthcare) slurry and incubated on a roller for 1 hour. Resin was washed 4x with 10 mL of suspension buffer and with 4x 10 mL of a wash buffer containing 50mM Tris•Cl pH 7.5, 150mM NaCl, 10% glycerol, 0.1% Tween-20, 1mM DTT. Resin was then incubated for 2 hours with 400 uL of 1mg/mL PreScission protease (PP) in 15 mL of wash buffer additionally containing 1% Tween-20, 0.5 mM EDTA•Na2, plus protease and phosphatase inhibitors as above. Eluent was combined with an additional 2x 20 mL of wash buffer and subsequently applied to a 5 mL HiTrap Q (GE Healthcare) ion-exchange column equilibrated in a buffer containing 25 mM Tris•Cl, 5% glycerol, 0.5mM EDTA•Na2, and 2mM 2-mercaptoethanol, and eluted over a gradient from 0 mM to 1 M NaCl. Tom1p eluted at approximately 500 mM NaCl. Fractions containing Tom1p were then pooled, concentrated, and loaded onto a Superdex S6 size exclusion column (GE Healthcare) equilibrated in 5% glycerol, 50 mM Tris•Cl pH 7.5, 150 mM NaCl, and 2 mM DTT. Fractions containing Tom1p were pooled and concentrated.</p>
</sec>
<sec id="s4c4">
<title>Tom1p<sup>His</sup></title>
<p><italic>S. cerevisiae</italic> strain 10293 (Tom1p<sup>His</sup>) was purified as above, with the following differences: DTT was replaced by 2.5 mM 2-mercaptoethanol in the lysis buffer, IgG beads were replaced by 3.5 mL Nickel beads. Wash buffer contained 25 mM Tris•Cl pH 6.8, 125 mM NaCl, 5 mM imidazole, and no DTT. Elution buffer contained 25mM Tris•Cl pH 6.8, 125 mM NaCl, 10% glycerol, 0.1% Tween-20, 500 mM imidazole, 0.5 mM EDTA•Na2, 10 mM 2-mercaptoethanol, plus protease and phosphatase inhibitors as above. Resin was washed 3x with 2 CV lysis buffer, 1x 2 CV lysis buffer containing 0.2ul RNAse A first incubated for 5 minutes, 3x 2 CV wash buffer, and 4x 2 CV Elution buffer. Before application to HiTrap Q column, eluent was dialyzed overnight at 4 °C into 2L of an elution buffer containing 7.5% glycerol, no imidazole, and 2.5 mM 2-mercaptoethanol.</p>
</sec>
</sec>
<sec id="s4d">
<title>Far-Western blots</title>
<p>Far-western blots were performed essentially as described previously (<xref ref-type="bibr" rid="c66">Wu et al. 2007</xref>). Either 20 μL of the FLAG elution described above or 1.1 pmol purified Tom1p were loaded to a NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gel (Invitrogen) and electrophoresed in MOPS buffer. Proteins were transferred to nitrocellulose membranes for 70 minutes at 100 V. After a 1-hour in blocking buffer (1xTBS, 3% milk powder) the membrane was incubated in GST-Spt6p<sup>tSH2</sup> protein in binding buffer (100 mM NaCl, 20 mM Tris•Cl, 10% glycerol, 3% milk powder, 0.2% EDTA•Na2, 0.1% Tween-20, 0.1% DTT, 50 nM GST-Spt6p<sup>tSH2</sup>) overnight at 4°C. Anti-GST primary antibody was used at 1:1,000 (GE Healthcare 27-4577-01) and secondary antibody was conjugate to Alexa 680 nm dye at 1:10,000, washing with 1xTBS between steps.</p>
<p>For phosphatase treatment, purified Tom1p was diluted to 300 nM in phosphatase buffer (50 mM Tris•Cl pH 7.5, 100 mM NaCl, 10 mM MgCl<sub>2</sub>, 5% glycerol, 0.1% Tween-20, 1 mM DTT, 1x protease inhibitors) and incubated with 0.3 U/μl CIP (New England BioLabs) for 1 hour at room temperature prior to loading onto a gel.</p>
</sec>
<sec id="s4e">
<title>Limited proteolysis</title>
<p>100 μg of purified Tom1p was incubated with 100 ng trypsin in 200 μL sizing buffer at room temperature. Time points were collected at 30 seconds, and 1, 3, 10, 20 and 30 minutes. Reactions were quenched by the addition of aprotinin, leupeptin, PMSF, and SDS-loading dye followed by boiling for 3 minutes. Time points were resolved by SDS-PAGE on NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gels (Invitrogen) in MOPS running buffer, and proteins were visualized by Coomassie staining or transferred to a membrane for far western blotting.</p>
</sec>
<sec id="s4f">
<title>Mass spectrometry</title>
<p>LC/MS/MS analyses of the Spt6p Tom1p-binding domain visualized from limited proteolysis and identification of the Tom1p protein (<xref rid="fig2" ref-type="fig">Figure 2B</xref>) were performed as described (<xref ref-type="bibr" rid="c53">Sdano et al. 2017</xref>). Proteomics mass spectrometry analysis was performed at the Mass Spectrometry and Proteomics Core Facility at the University of Utah.</p>
</sec>
<sec id="s4g">
<title>Western blots</title>
<p>Western blots were performed as previously described except 60 µg of total protein was loaded per lane (<xref ref-type="bibr" rid="c36">McCullough et al. 2015</xref>), and antiserum obtained from a rabbit injected with purified Tom1p protein was used (Covance). Specificity of the antiserum was validated using strains lacking Tom1p (see <xref rid="fig2" ref-type="fig">Fig. 2C</xref>).</p>
</sec>
<sec id="s4h">
<title>Cryo-EM specimen grid preparation</title>
<p>Specimens were prepared on Quantifoil R 2/2 Cu300 grids after glow discharge for 1 minute at 25 mA. For Tom1p<sup>ΔAD</sup> samples, Tom1p<sup>ΔAD</sup> was concentrated to 8.1 mg/mL in 0.01% CHAPS and 0.05% NP-40. 2.5 μL of sample was applied to grids and blotted for 2.5 seconds before vitrification by plunging into liquid ethane. For Tom1p<sup>ΔAD</sup> samples without detergent, protein was concentrated to 0.44 mg/mL and blotted for 1.5 seconds before vitrification. For Tom1p<sup>His</sup>, protein samples were prepared as for Tom1p<sup>ΔAD</sup> without detergent and concentrated to 0.5 mg/mL. 2.5 μL of sample was added to grids and blotted for 2.5 seconds before vitrification.</p>
</sec>
<sec id="s4i">
<title>Cryo-EM data collection</title>
<p>A total of 2,865 movies were recorded from Tom1p<sup>ΔAD</sup> grids without detergent at 81,000x magnification on a 300 kV Titan Krios G3 electron microscope with a K3 direct detector (nominal resolution after 2x binning is 1.06Å/px). Electron exposure was 47 (e-/Å<sup>2</sup>) over a total of 40 frames. A total of 4,371 movies were recorded from Tom1p<sup>ΔAD</sup> with detergent grids using the same electron microscope and collection parameters. A total of 3,630 movies were recorded from Tom1p<sup>His</sup> grids using the same electron microscope and collection parameters, with a total electron exposure of 40 (e-/Å2) over 40 frames.</p>
</sec>
<sec id="s4j">
<title>Cryo-EM data processing</title>
<p>Cryo-EM data processing was performed in CryoSPARC (<xref ref-type="bibr" rid="c50">Punjani et al. 2017</xref>). Movies were motion-corrected for all 3 datasets using CryoSPARC Patch Motion Correction. CTF estimation was performed on motion-corrected micrographs using CryoSPARC Patch CTF with default parameters applied.</p>
<sec id="s4j1">
<title>Dataset #1: Tom1p<sup>ΔAD</sup>-no detergent</title>
<p>Initial ‘blob’ auto-picking, 2D classification, <italic>ab initio</italic> reconstructions and heterogeneous refinements led to 3 refined volumes. Templates were low-pass filtered to 17 Å creating 25 equally spaced templates each for a total of 75 templates. These templates were used to template-pick from 2,139 micrographs selected from the original 2,865 by CTF resolution (max 5.6 Å CTF estimated resolution). An initial set of 792,807 particles was filtered by 2D classification to 513,104 particles, followed by <italic>ab initio</italic> volume creation to generate 5 classes. Three of the classes were removed as junk and the remaining particles subjected to additional 2D and 3D classification to yield 235,202 particles that were combined with particles from the Tom1p<sup>ΔAD</sup>-detergent dataset for downstream processing.</p>
</sec>
<sec id="s4j2">
<title>Dataset #2: Tom1p<sup>ΔAD</sup>-detergent</title>
<p>4,356 of the 4,371 micrographs from the Tom1p<sup>ΔAD</sup>-detergent dataset were selected after inspection of CTF estimation, and the 75 templates from Dataset #1 (above) were used to select 544,686 template-picked particles. Multiple rounds of 2D and 3D classification were used to remove junk and any open- or intermediate-conformation particles, which narrowed the selection to 296,347 particles.</p>
</sec>
<sec id="s4j3">
<title>Combined Datasets #1/#2: Tom1p<sup>ΔAD</sup></title>
<p>The separately processed dataset #1 and #2 particles were combined for a total of 531,549 starting particles for further processing and refinement. A round of 2D classification resulted in selection of 477,889 particles, which were Fourier cropped from a box size of 680 to 320 pixels for further processing. Two-component 3DVA was performed after map refinement of the combined dataset with a filter resolution of 4 Å. 3DVA display was subsequently run to give 8 intermediates along the first principal component at a filter resolution of 5 Å. The top 4 intermediates with the highest number of particles were combined to yield 462,711 and refined using non-uniform refinement to an estimated overall resolution of 3.07 Å.</p>
</sec>
<sec id="s4j4">
<title>Dataset #3: Tom1p<sup>His</sup></title>
<p>3,522 of 3,630 micrographs were selected for particle picking from grids containing Tom1p<sup>His</sup>. Initial blob picks were curated via 2D-classification and 3D ab initio jobs to create 60 2D templates for template-picking. 1,434,189 template-picked particles (lowpass filter 15 Å) were narrowed through 6 rounds of 2D classification to give 201,930 particles, which were input to <italic>ab initio</italic> volume creation with 4 classes. As outlined below, 41,253 particles from one of these classes were used to refine the open/intermediate conformations and 160,667 total particles from the remaining 3 classes were combined for further refinement of the closed conformation map.</p>
<p>Closed conformation: The selected 160,667 particles were combined for 4-class 3D <italic>ab initio</italic> volume creation to remove one junk class. 2D classification on the remaining particles was used to remove 6,726 additional junk/low-resolution particles, and ab initio and NU-refinement was performed on the final 142,020 particles, resulting in a closed-conformation map at an estimated overall resolution of 3.97 Å.</p>
<p>Open/intermediate conformations: The selected 41,253 particles were assessed for <italic>ab initio</italic> reconstruction in 4 classes. NU-refinement was performed on 2 of these classes to give an intermediate-conformation map at 7.79 Å resolution from 12,397 particles and an open-conformation map at 7.10 Å from 16,098 particles.</p>
</sec>
</sec>
<sec id="s4k">
<title>Model building and refinement</title>
<p>Initial model building into the Tom1p<sup>ΔAD</sup> closed-conformation map was done in Coot v.0.9.6 via Xquartz 2.8.2 as part of the CCP4-7.1 Program Suite (<xref ref-type="bibr" rid="c15">Emsley et al. 2010</xref>). In parallel with <italic>ab initio</italic> model building, portions of the sequence were predicted iteratively for the entire protein, approximately 200-500 residues at a time, using the AlphaFold2 algorithm employed by ColabFold v.1.0 and accessed via a Google Colab Jupyter Notebook (<xref ref-type="bibr" rid="c41">Mirdita et al. 2022</xref>). The top models predicted for each segment of sequence were compared with the corresponding portions of the manually built model and used for validation of residue placement and additional model refinement. The HECT domain model was built by fitting the x-ray structure of the Tom1p HECT domain to the density. The model was then subject to Real Space Refinement via Phenix v.1.19.1.(<xref ref-type="bibr" rid="c1">Afonine et al. 2018</xref>) using secondary structure restraints and a target bond/angle RMSD of 0.1 Å and 1.56°, respectively. Statistics are summarized in Table S3. All model and map figure and movie generation were done via Chimera (<xref ref-type="bibr" rid="c46">Pettersen et al. 2004</xref>) or ChimeraX (<xref ref-type="bibr" rid="c39">Meng et al. 2023</xref>).</p>
</sec>
<sec id="s4l">
<title>Structural Cα alignment</title>
<p>The aligned Cα RMSD between the full sequence of yeast Tom1p and human HUWE1 structures was calculated using the Matchmaker function integrated in ChimeraX, applying the Needleman-Wunsch alignment algorithm, BLOSUM-62 similarity matrix (<xref ref-type="bibr" rid="c21">Goddard et al. 2018</xref>).</p>
</sec>
<sec id="s4m">
<title>X-ray structure of Tom1p HECT domain</title>
<p>An His-MBP-TEV-Tom1(HECT: 2850-3268) was expressed and purified according to standard protocols. Briefly TEV protease cleavage occurred overnight in dialysis to 15 mM Tris pH 7.5, 100 mM NaCl, 5% glycerol, 0.5 mM EDTA pH 8.0, 2 mM BME and then run on an S200 size exclusion column, from which it eluted as a monomeric peak. The protein was concentrated to 15 mg/mL prior to crystallization. Data were collected at SSRL beamline 12-2 with wavelength 0.97946 Å. Images were processed with XDS, Aimless, and Truncate in CCP4 (<xref ref-type="bibr" rid="c2">Agirre et al. 2023</xref>). (Table S4). The model was built and refined in Coot (<xref ref-type="bibr" rid="c15">Emsley et al. 2010</xref>) and Phenix (<xref ref-type="bibr" rid="c1">Afonine et al. 2018</xref>) to 3.3Å. The modeled structure includes residues 2852-3261, except residues 2904-2908, 2991-2996, 3079-3090 and 3064-3065. The structure was refined at 3.3Å resolution. The structure closely resembles the HUWE1 HECT domain structure (PDBcode:5lp8) with an overall RMSD of 0.9Å and only two areas of divergence. The HUWE1 structure contains a two ordered β-strands in the middle domain residues 4172-4196 whereas the Tom1p HECT contains disordered loop residues between 3078-3091.</p>
<p>Maps and models have been deposited to the EMDB and PDB respectively. Tom1<sup>ΔAD</sup> cryoEM maps closed (EMDB:XXXX/PDB:XXXX), intermediate map (EMDB:XXXX), open map (EMDB:XXXX), and the x-ray structure of the Tom1 HECT (PDB:XXXX). Plasmids were deposited to Addgene.org.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We gratefully acknowledge the support and resources of the University of Utah Center for High Performance Computing. We thank the University of Utah HCI Cores for ChIP, MNase, and nucleosome profiling, and the University of Utah HSC cores for DNA sequencing, Mass Spectrometry and Proteomics, and Electron Microscopy. We thank Dr. David Belnap for assistance with EM data collection and Dr. Frank Whitby for x-ray data collection. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). Core Facility Mass spectrometry equipment was obtained through NIH Grant S10 OD018210. CryoEM instrumentation was obtained with support from the Arnold and Mabel Beckman Foundation. This work was supported by NIH grants U54AI170856 (CPH) and GM064649 (TF). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIH.</p>
</ack>
<sec id="d1e1711" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1711a">
<label>Supplemental Information 1</label>
<media xlink:href="supplements/601072_file02.pdf"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Afonine</surname>, <given-names>P. V.</given-names></string-name>, <string-name><given-names>B. K.</given-names> <surname>Poon</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Read</surname></string-name>, <string-name><given-names>O. V.</given-names> <surname>Sobolev</surname></string-name>, <string-name><given-names>T. C.</given-names> <surname>Terwilliger</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Urzhumtsev</surname></string-name> and <string-name><given-names>P. D.</given-names> <surname>Adams</surname></string-name></person-group> (<year>2018</year>). “<article-title>Real-space refinement in PHENIX for cryo-EM and crystallography</article-title>.” <source>Acta Crystallogr D Struct Biol</source> <volume>74</volume>(<issue>Pt 6</issue>): <fpage>531</fpage>–<lpage>544</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agirre</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Atanasova</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Bagdonas</surname></string-name>, <string-name><given-names>C. B.</given-names> <surname>Ballard</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Basle</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Beilsten-Edmands</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Borges</surname></string-name>, <string-name><given-names>D. G.</given-names> <surname>Brown</surname></string-name>, <string-name><given-names>J. J.</given-names> <surname>Burgos-Marmol</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Berrisford</surname></string-name>, <string-name><given-names>P. S.</given-names> <surname>Bond</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Caballero</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Catapano</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Chojnowski</surname></string-name>, <string-name><given-names>A. G.</given-names> <surname>Cook</surname></string-name>, <string-name><given-names>K. D.</given-names> <surname>Cowtan</surname></string-name>, <string-name><given-names>T. I.</given-names> <surname>Croll</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Debreczeni</surname></string-name>, <string-name><given-names>N. E.</given-names> <surname>Devenish</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Dodson</surname></string-name>, <string-name><given-names>T. R.</given-names> <surname>Drevon</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Emsley</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Evans</surname></string-name>, <string-name><given-names>P. R.</given-names> <surname>Evans</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Fando</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Foadi</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Fuentes-Montero</surname></string-name>, <string-name><given-names>E. F.</given-names> <surname>Garman</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Gerstel</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Gildea</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Hatti</surname></string-name>, <string-name><given-names>M. L.</given-names> <surname>Hekkelman</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Heuser</surname></string-name>, <string-name><given-names>S. W.</given-names> <surname>Hoh</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Hough</surname></string-name>, <string-name><given-names>H. T.</given-names> <surname>Jenkins</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Jimenez</surname></string-name>, <string-name><given-names>R. P.</given-names> <surname>Joosten</surname></string-name>, <string-name><given-names>R. M.</given-names> <surname>Keegan</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Keep</surname></string-name>, <string-name><given-names>E. B.</given-names> <surname>Krissinel</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Kolenko</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Kovalevskiy</surname></string-name>, <string-name><given-names>V. S.</given-names> <surname>Lamzin</surname></string-name>, <string-name><given-names>D. M.</given-names> <surname>Lawson</surname></string-name>, <string-name><given-names>A. A.</given-names> <surname>Lebedev</surname></string-name>, <string-name><given-names>A. G. W.</given-names> <surname>Leslie</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Lohkamp</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Long</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Maly</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>McCoy</surname></string-name>, <string-name><given-names>S. J.</given-names> <surname>McNicholas</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Medina</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Millan</surname></string-name>, <string-name><given-names>J. W.</given-names> <surname>Murray</surname></string-name>, <string-name><given-names>G. N.</given-names> <surname>Murshudov</surname></string-name>, <string-name><given-names>R. A.</given-names> <surname>Nicholls</surname></string-name>, <string-name><given-names>M. E. M.</given-names> <surname>Noble</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Oeffner</surname></string-name>, <string-name><given-names>N. S.</given-names> <surname>Pannu</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Parkhurst</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Pearce</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Pereira</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Perrakis</surname></string-name>, <string-name><given-names>H. R.</given-names> <surname>Powell</surname></string-name>, <string-name><given-names>R. J.</given-names> <surname>Read</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Rigden</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Rochira</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sammito</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Sanchez Rodriguez</surname></string-name>, <string-name><given-names>G. M.</given-names> <surname>Sheldrick</surname></string-name>, <string-name><given-names>K. L.</given-names> <surname>Shelley</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Simkovic</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Simpkin</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Skubak</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Sobolev</surname></string-name>, <string-name><given-names>R. A.</given-names> <surname>Steiner</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Stevenson</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Tews</surname></string-name>, <string-name><given-names>J. M. H.</given-names> <surname>Thomas</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Thorn</surname></string-name>, <string-name><given-names>J. T.</given-names> <surname>Valls</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Uski</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Uson</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Vagin</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Velankar</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Vollmar</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Walden</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Waterman</surname></string-name>, <string-name><given-names>K. S.</given-names> <surname>Wilson</surname></string-name>, <string-name><given-names>M. D.</given-names> <surname>Winn</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Winter</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Wojdyr</surname></string-name> and <string-name><given-names>K.</given-names> <surname>Yamashita</surname></string-name></person-group> (<year>2023</year>). “<article-title>The CCP4 suite: integrative software for macromolecular crystallography</article-title>.” <source>Acta Crystallogr D Struct Biol</source> <volume>79</volume>(<issue>Pt 6</issue>): <fpage>449</fpage>–<lpage>461</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amici</surname>, <given-names>D. R.</given-names></string-name>, <string-name><given-names>D. J.</given-names> <surname>Ansel</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Metz</surname></string-name>, <string-name><given-names>R. S.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>Phoumyvong</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Gayatri</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Chamera</surname></string-name>, <string-name><given-names>S. L.</given-names> <surname>Edwards</surname></string-name>, <string-name><given-names>B. P.</given-names> <surname>O’Hara</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Srivastava</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Brockway</surname></string-name>, <string-name><given-names>S. R.</given-names> <surname>Takagishi</surname></string-name>, <string-name><given-names>B. K.</given-names> <surname>Cho</surname></string-name>, <string-name><given-names>Y. A.</given-names> <surname>Goo</surname></string-name>, <string-name><given-names>N. L.</given-names> <surname>Kelleher</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Ben-Sahra</surname></string-name>, <string-name><given-names>D. R.</given-names> <surname>Foltz</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Li</surname></string-name> and <string-name><given-names>M. L.</given-names> <surname>Mendillo</surname></string-name></person-group> (<year>2022</year>). “<article-title>C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways</article-title>.” <source>Proc Natl Acad Sci U S A</source> <volume>119</volume>(<issue>27</issue>): <fpage>e2111262119</fpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andoh</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>A. K.</given-names> <surname>Azad</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Shigematsu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Ohshima</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Tani</surname></string-name></person-group> (<year>2004</year>). “<article-title>The fission yeast ptr1+ gene involved in nuclear mRNA export encodes a putative ubiquitin ligase</article-title>.” <source>Biochem Biophys Res Commun</source> <volume>317</volume>(<issue>4</issue>): <fpage>1138</fpage>–<lpage>1143</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ardehali</surname>, <given-names>M. B.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Yao</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Adelman</surname></string-name>, <string-name><given-names>N. J.</given-names> <surname>Fuda</surname></string-name>, <string-name><given-names>S. J.</given-names> <surname>Petesch</surname></string-name>, <string-name><given-names>W. W.</given-names> <surname>Webb</surname></string-name> and <string-name><given-names>J. T.</given-names> <surname>Lis</surname></string-name></person-group> (<year>2009</year>). “<article-title>Spt6 enhances the elongation rate of RNA polymerase II in vivo</article-title>.” <source>EMBO J</source> <volume>28</volume>(<issue>8</issue>): <fpage>1067</fpage>–<lpage>1077</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Atsumi</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Minakawa</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ono</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Dobashi</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Shinohe</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Shinohara</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Takeda</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Takagi</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Takamatsu</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Nakagama</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Teraoka</surname></string-name> and <string-name><given-names>K.</given-names> <surname>Yoshioka</surname></string-name></person-group> (<year>2015</year>). “<article-title>ATM and SIRT6/SNF2H Mediate Transient H2AX Stabilization When DSBs Form by Blocking HUWE1 to Allow Efficient gammaH2AX Foci Formation</article-title>.” <source>Cell Rep</source> <volume>13</volume>(<issue>12</issue>): <fpage>2728</fpage>–<lpage>2740</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brachmann</surname>, <given-names>C. B.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Davies</surname></string-name>, <string-name><given-names>G. J.</given-names> <surname>Cost</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Caputo</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Hieter</surname></string-name> and <string-name><given-names>J. D.</given-names> <surname>Boeke</surname></string-name></person-group> (<year>1998</year>). “<article-title>Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications</article-title>.” <source>Yeast</source> <volume>14</volume>(<issue>2</issue>): <fpage>115</fpage>–<lpage>132</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chun</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>Y. J.</given-names> <surname>Joo</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Suh</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Batot</surname></string-name>, <string-name><given-names>C. P.</given-names> <surname>Hill</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name> and <string-name><given-names>S.</given-names> <surname>Buratowski</surname></string-name></person-group> (<year>2019</year>). “<article-title>Selective Kinase Inhibition Shows That Bur1 (Cdk9) Phosphorylates the Rpb1 Linker In Vivo</article-title>.” <source>Mol Cell Biol</source> <volume>39</volume>(<fpage>15</fpage>).</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Close</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>S. J.</given-names> <surname>Johnson</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Sdano</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>McDonald</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Robinson</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name> and <string-name><given-names>C. P.</given-names> <surname>Hill</surname></string-name></person-group> (<year>2011</year>). “<article-title>Crystal structures of the S. cerevisiae Spt6 core and C-terminal tandem SH2 domain</article-title>.” <source>J Mol Biol</source> <volume>408</volume>(<issue>4</issue>): <fpage>697</fpage>–<lpage>713</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Connell</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>T. J.</given-names> <surname>Parnell</surname></string-name>, <string-name><given-names>L. L.</given-names> <surname>McCullough</surname></string-name>, <string-name><given-names>C. P.</given-names> <surname>Hill</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name></person-group> (<year>2022</year>). “<article-title>The interaction between the Spt6-tSH2 domain and Rpb1 affects multiple functions of RNA Polymerase II</article-title>.” <source>Nucleic Acids Res</source> <volume>50</volume>(<issue>2</issue>): <fpage>784</fpage>–<lpage>802</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Defenouillere</surname>, <given-names>Q.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Namane</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Mouaikel</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Jacquier</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Fromont-Racine</surname></string-name></person-group> (<year>2017</year>). “<article-title>The ribosome-bound quality control complex remains associated to aberrant peptides during their proteasomal targeting and interacts with Tom1 to limit protein aggregation</article-title>.” <source>Mol Biol Cell</source> <volume>28</volume>(<issue>9</issue>): <fpage>1165</fpage>–<lpage>1176</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Diebold</surname>, <given-names>M. L.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Koch</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Loeliger</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Cura</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Winston</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Cavarelli</surname></string-name> and <string-name><given-names>C.</given-names> <surname>Romier</surname></string-name></person-group> (<year>2010</year>). “<article-title>The structure of an Iws1/Spt6 complex reveals an interaction domain conserved in TFIIS, Elongin A and Med26</article-title>.” <source>EMBO J</source> <volume>29</volume>(<issue>23</issue>): <fpage>3979</fpage>–<lpage>3991</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Duncan</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>J. G.</given-names> <surname>Umen</surname></string-name> and <string-name><given-names>C.</given-names> <surname>Guthrie</surname></string-name></person-group> (<year>2000</year>). “<article-title>A putative ubiquitin ligase required for efficient mRNA export differentially affects hnRNP transport</article-title>.” <source>Curr Biol</source> <volume>10</volume>(<issue>12</issue>): <fpage>687</fpage>–<lpage>696</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ellison</surname>, <given-names>M. A.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Namjilsuren</surname></string-name>, <string-name><given-names>Margaret K.</given-names> <surname>Shirra</surname></string-name>, <string-name><given-names>Matthew S.</given-names> <surname>Blacksmith</surname></string-name>, <string-name><given-names>Rachel A.</given-names> <surname>Schusteff</surname></string-name>, <string-name><given-names>Eleanor M.</given-names> <surname>Kerr</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Fang</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Xiang</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Shi</surname></string-name> and <string-name><given-names>Karen M.</given-names> <surname>Arndt</surname></string-name></person-group> (<year>2023</year>). “<article-title>Spt6 directly interacts with Cdc73 and is required for Paf1 complex occupancy at active genes in Saccharomyces cerevisiae</article-title>.” <source>Nucleic Acids Research: gkad</source><volume>180</volume>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Emsley</surname>, <given-names>P.</given-names></string-name>, <string-name><given-names>B.</given-names> <surname>Lohkamp</surname></string-name>, <string-name><given-names>W. G.</given-names> <surname>Scott</surname></string-name> and <string-name><given-names>K.</given-names> <surname>Cowtan</surname></string-name></person-group> (<year>2010</year>). “<article-title>Features and development of Coot</article-title>.” <source>Acta Crystallogr D Biol Crystallogr</source> <volume>66</volume>(<issue>Pt 4</issue>): <fpage>486</fpage>–<lpage>501</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Endoh</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>W.</given-names> <surname>Zhu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Hasegawa</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Watanabe</surname></string-name>, <string-name><given-names>D. K.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Aida</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Inukai</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Narita</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Yamada</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Furuya</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Sato</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Yamaguchi</surname></string-name>, <string-name><given-names>S. S.</given-names> <surname>Mandal</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Reinberg</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Wada</surname></string-name> and <string-name><given-names>H.</given-names> <surname>Handa</surname></string-name></person-group> (<year>2004</year>). “<article-title>Human Spt6 stimulates transcription elongation by RNA polymerase II in vitro</article-title>.” <source>Mol Cell Biol</source> <volume>24</volume>(<issue>8</issue>): <fpage>3324</fpage>–<lpage>3336</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Endres</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>Solvie</surname></string-name>, <string-name><given-names>J. B.</given-names> <surname>Heidelberger</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Andrioletti</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Baluapuri</surname></string-name>, <string-name><given-names>C. P.</given-names> <surname>Ade</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Muhar</surname></string-name>, <string-name><given-names>U.</given-names> <surname>Eilers</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>Vos</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Cramer</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zuber</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Beli</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Popov</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Wolf</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Gallant</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Eilers</surname></string-name></person-group> (<year>2021</year>). “<article-title>Ubiquitylation of MYC couples transcription elongation with double-strand break repair at active promoters</article-title>.” <source>Mol Cell</source> <volume>81</volume>(<issue>4</issue>): <fpage>830</fpage>–<lpage>844.</lpage> </mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Froyen</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Belet</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Martinez</surname></string-name>, <string-name><given-names>C. B.</given-names> <surname>Santos-Reboucas</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Declercq</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Verbeeck</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Donckers</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Berland</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Mayo</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Rosello</surname></string-name>, <string-name><given-names>M. M.</given-names> <surname>Pimentel</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Fintelman-Rodrigues</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Hovland</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Rodrigues dos Santos</surname></string-name>, <string-name><given-names>F. L.</given-names> <surname>Raymond</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Bose</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Corbett</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Sheffield</surname></string-name>, <string-name><given-names>C. M.</given-names> <surname>van Ravenswaaij-Arts</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Dijkhuizen</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Coutton</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Satre</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Siu</surname></string-name> and <string-name><given-names>P.</given-names> <surname>Marynen</surname></string-name></person-group> (<year>2012</year>). “<article-title>Copy-number gains of HUWE1 due to replication- and recombination-based rearrangements</article-title>.” <source>Am J Hum Genet</source> <volume>91</volume>(<issue>2</issue>): <fpage>252</fpage>–<lpage>264</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Froyen</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Corbett</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Vandewalle</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Jarvela</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Lawrence</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Meldrum</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Bauters</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Govaerts</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Vandeleur</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Van Esch</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chelly</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Sanlaville</surname></string-name>, <string-name><given-names>H.</given-names> <surname>van Bokhoven</surname></string-name>, <string-name><given-names>H. H.</given-names> <surname>Ropers</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Laumonnier</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Ranieri</surname></string-name>, <string-name><given-names>C. E.</given-names> <surname>Schwartz</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Abidi</surname></string-name>, <string-name><given-names>P. S.</given-names> <surname>Tarpey</surname></string-name>, <string-name><given-names>P. A.</given-names> <surname>Futreal</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Whibley</surname></string-name>, <string-name><given-names>F. L.</given-names> <surname>Raymond</surname></string-name>, <string-name><given-names>M. R.</given-names> <surname>Stratton</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Fryns</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Scott</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Peippo</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sipponen</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Partington</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Mowat</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Field</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Hackett</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Marynen</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Turner</surname></string-name> and <string-name><given-names>J.</given-names> <surname>Gecz</surname></string-name></person-group> (<year>2008</year>). “<article-title>Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation</article-title>.” <source>Am J Hum Genet</source> <volume>82</volume>(<issue>2</issue>): <fpage>432</fpage>–<lpage>443</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gloeckner</surname>, <given-names>C. J.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Boldt</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Schumacher</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Roepman</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Ueffing</surname></string-name></person-group> (<year>2007</year>). “<article-title>A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes</article-title>.” <source>Proteomics</source> <volume>7</volume>(<issue>23</issue>): <fpage>4228</fpage>–<lpage>4234</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goddard</surname>, <given-names>T. D.</given-names></string-name>, <string-name><given-names>C. C.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>E. C.</given-names> <surname>Meng</surname></string-name>, <string-name><given-names>E. F.</given-names> <surname>Pettersen</surname></string-name>, <string-name><given-names>G. S.</given-names> <surname>Couch</surname></string-name>, <string-name><given-names>J. H.</given-names> <surname>Morris</surname></string-name> and <string-name><given-names>T. E.</given-names> <surname>Ferrin</surname></string-name></person-group> (<year>2018</year>). “<article-title>UCSF ChimeraX: Meeting modern challenges in visualization and analysis</article-title>.” <source>Protein Sci</source> <volume>27</volume>(<issue>1</issue>): <fpage>14</fpage>–<lpage>25</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grabarczyk</surname>, <given-names>D. B.</given-names></string-name>, <string-name><given-names>O. A.</given-names> <surname>Petrova</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Deszcz</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Kurzbauer</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Murphy</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ahel</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Vogel</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Gogova</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Faas</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kordic</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Schleiffer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Meinhart</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Imre</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Lehner</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Neuhold</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Bader</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Stolt-Bergner</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Bottcher</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Wolkerstorfer</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Fischer</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Grishkovskaya</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Haselbach</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kessler</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Clausen</surname></string-name></person-group> (<year>2021</year>). “<article-title>HUWE1 employs a giant substrate-binding ring to feed and regulate its HECT E3 domain</article-title>.” <source>Nat Chem Biol</source> <volume>17</volume>(<issue>10</issue>): <fpage>1084</fpage>–<lpage>1092</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname>, <given-names>J. R.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Kow</surname></string-name>, <string-name><given-names>K. R.</given-names> <surname>Nevis</surname></string-name>, <string-name><given-names>C. K.</given-names> <surname>Lu</surname></string-name>, <string-name><given-names>K. S.</given-names> <surname>Luce</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Zhong</surname></string-name> and <string-name><given-names>J. G.</given-names> <surname>Cook</surname></string-name></person-group> (<year>2007</year>). “<article-title>Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage</article-title>.” <source>Mol Biol Cell</source> <volume>18</volume>(<issue>9</issue>): <fpage>3340</fpage>–<lpage>3350</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herold</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Hock</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Herkert</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Berns</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Mullenders</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Beijersbergen</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Bernards</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Eilers</surname></string-name></person-group> (<year>2008</year>). “<article-title>Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1</article-title>.” <source>EMBO J</source> <volume>27</volume>(<issue>21</issue>): <fpage>2851</fpage>–<lpage>2861</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hunkeler</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>C. Y.</given-names> <surname>Jin</surname></string-name>, <string-name><given-names>M. W.</given-names> <surname>Ma</surname></string-name>, <string-name><given-names>J. K.</given-names> <surname>Monda</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Overwijn</surname></string-name>, <string-name><given-names>E. J.</given-names> <surname>Bennett</surname></string-name> and <string-name><given-names>E. S.</given-names> <surname>Fischer</surname></string-name></person-group> (<year>2021</year>). “<article-title>Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognition</article-title>.” <source>Mol Cell</source> <volume>81</volume>(<issue>17</issue>): <fpage>3468</fpage>–<lpage>3480.</lpage> </mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname>, <given-names>C.-S.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Shemorry</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Auerbach</surname></string-name> and <string-name><given-names>A.</given-names> <surname>Varshavsky</surname></string-name></person-group> (<year>2010</year>). “<article-title>The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases</article-title>.” <source>Nature Cell Biology</source> <volume>12</volume>(<issue>12</issue>): <fpage>1177</fpage>–<lpage>1185</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iglesias</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Tutucci</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Gwizdek</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Vinciguerra</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Von Dach</surname></string-name>, <string-name><given-names>A. H.</given-names> <surname>Corbett</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Dargemont</surname></string-name> and <string-name><given-names>F.</given-names> <surname>Stutz</surname></string-name></person-group> (<year>2010</year>). “<article-title>Ubiquitin-mediated mRNP dynamics and surveillance prior to budding yeast mRNA export</article-title>.” <source>Genes Dev</source> <volume>24</volume>(<issue>17</issue>): <fpage>1927</fpage>–<lpage>1938</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ilia</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Christian</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Marc</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Anton</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Laura</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Thomas</surname></string-name> and <string-name><given-names>K.</given-names> <surname>Michael</surname></string-name></person-group> (<year>2022</year>). “<article-title>Up-regulation of ubiquitin–proteasome activity upon loss of NatA-dependent N-terminal acetylation</article-title>.” <source>Life Science Alliance</source> <volume>5</volume>(<issue>2</issue>): <fpage>e202000730</fpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Inoue</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>Z.</given-names> <surname>Hao</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Elia</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Cescon</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Silvester</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Snow</surname></string-name>, <string-name><given-names>I. S.</given-names> <surname>Harris</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sasaki</surname></string-name>, <string-name><given-names>W. Y.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Itsumi</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Yamamoto</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Ueda</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Dominguez-Brauer</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Gorrini</surname></string-name>, <string-name><surname>Chio</surname>, <given-names>II</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Haight</surname></string-name>, <string-name><given-names>A.</given-names> <surname>You-Ten</surname></string-name>, <string-name><given-names>S.</given-names> <surname>McCracken</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Wakeham</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Ghazarian</surname></string-name>, <string-name><given-names>L. J.</given-names> <surname>Penn</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Melino</surname></string-name> and <string-name><given-names>T. W.</given-names> <surname>Mak</surname></string-name></person-group> (<year>2013</year>). “<article-title>Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15</article-title>.” <source>Genes Dev</source> <volume>27</volume>(<issue>10</issue>): <fpage>1101</fpage>–<lpage>1114</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Isrie</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>V. M.</given-names> <surname>Kalscheuer</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Holvoet</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Fieremans</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Van Esch</surname></string-name> and <string-name><given-names>K.</given-names> <surname>Devriendt</surname></string-name></person-group> (<year>2013</year>). “<article-title>HUWE1 mutation explains phenotypic severity in a case of familial idiopathic intellectual disability</article-title>.” <source>Eur J Med Genet</source> <volume>56</volume>(<issue>7</issue>): <fpage>379</fpage>–<lpage>382</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kamadurai</surname>, <given-names>H. B.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Souphron</surname></string-name>, <string-name><given-names>D. C.</given-names> <surname>Scott</surname></string-name>, <string-name><given-names>D. M.</given-names> <surname>Duda</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Miller</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Stringer</surname></string-name>, <string-name><given-names>R. C.</given-names> <surname>Piper</surname></string-name> and <string-name><given-names>B. A.</given-names> <surname>Schulman</surname></string-name></person-group> (<year>2009</year>). “<article-title>Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex</article-title>.” <source>Mol Cell</source> <volume>36</volume>(<issue>6</issue>): <fpage>1095</fpage>–<lpage>1102</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kane</surname>, <given-names>E. I.</given-names></string-name>, <string-name><given-names>S. A.</given-names> <surname>Beasley</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Schafer</surname></string-name>, <string-name><given-names>J. E.</given-names> <surname>Bohl</surname></string-name>, <string-name><given-names>Y. S.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>K. J.</given-names> <surname>Rich</surname></string-name>, <string-name><given-names>E. F.</given-names> <surname>Bosia</surname></string-name> and <string-name><given-names>D. E.</given-names> <surname>Spratt</surname></string-name></person-group> (<year>2022</year>). “<article-title>Redefining the catalytic HECT domain boundaries for the HECT E3 ubiquitin ligase family</article-title>.” <source>Biosci Rep</source> <volume>42</volume>(<fpage>10</fpage>).</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>, <given-names>D. H.</given-names></string-name> and <string-name><given-names>D. M.</given-names> <surname>Koepp</surname></string-name></person-group> (<year>2012</year>). “<article-title>Hect E3 ubiquitin ligase Tom1 controls Dia2 degradation during the cell cycle</article-title>.” <source>Mol Biol Cell</source> <volume>23</volume>(<issue>21</issue>): <fpage>4203</fpage>–<lpage>4211</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname>, <given-names>D. H.</given-names></string-name>, <string-name><given-names>W.</given-names> <surname>Zhang</surname></string-name> and <string-name><given-names>D. M.</given-names> <surname>Koepp</surname></string-name></person-group> (<year>2012</year>). “<article-title>The Hect domain E3 ligase Tom1 and the F-box protein Dia2 control Cdc6 degradation in G1 phase</article-title>.” <source>J Biol Chem</source> <volume>287</volume>(<issue>53</issue>): <fpage>44212</fpage>–<lpage>44220</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marin</surname>, <given-names>I</given-names></string-name></person-group>. (<year>2018</year>). “<article-title>Origin and evolution of fungal HECT ubiquitin ligases</article-title>.” <source>Sci Rep</source> <volume>8</volume>(<issue>1</issue>): <fpage>6419</fpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCullough</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>Z.</given-names> <surname>Connell</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Petersen</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name></person-group> (<year>2015</year>). “<article-title>The Abundant Histone Chaperones Spt6 and FACT Collaborate to Assemble, Inspect, and Maintain Chromatin Structure in Saccharomyces cerevisiae</article-title>.” <source>Genetics</source> <volume>201</volume>(<issue>3</issue>): <fpage>1031</fpage>–<lpage>1045</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCullough</surname>, <given-names>L. L.</given-names></string-name>, <string-name><given-names>Z.</given-names> <surname>Connell</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Xin</surname></string-name>, <string-name><given-names>V. M.</given-names> <surname>Studitsky</surname></string-name>, <string-name><given-names>A. V.</given-names> <surname>Feofanov</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Valieva</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name></person-group> (<year>2018</year>). “<article-title>Functional roles of the DNA-binding HMGB domain in the histone chaperone FACT in nucleosome reorganization</article-title>.” <source>J Biol Chem</source> <volume>293</volume>(<issue>16</issue>): <fpage>6121</fpage>–<lpage>6133</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McDonald</surname>, <given-names>S. M.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>Close</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Xin</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name> and <string-name><given-names>C. P.</given-names> <surname>Hill</surname></string-name></person-group> (<year>2010</year>). “<article-title>Structure and biological importance of the Spn1-Spt6 interaction, and its regulatory role in nucleosome binding</article-title>.” <source>Mol Cell</source> <volume>40</volume>(<issue>5</issue>): <fpage>725</fpage>–<lpage>735</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname>, <given-names>E. C.</given-names></string-name>, <string-name><given-names>T. D.</given-names> <surname>Goddard</surname></string-name>, <string-name><given-names>E. F.</given-names> <surname>Pettersen</surname></string-name>, <string-name><given-names>G. S.</given-names> <surname>Couch</surname></string-name>, <string-name><given-names>Z. J.</given-names> <surname>Pearson</surname></string-name>, <string-name><given-names>J. H.</given-names> <surname>Morris</surname></string-name> and <string-name><given-names>T. E.</given-names> <surname>Ferrin</surname></string-name></person-group> (<year>2023</year>). “<article-title>UCSF ChimeraX: Tools for structure building and analysis</article-title>.” <source>Protein Sci</source> <volume>32</volume>(<issue>11</issue>): <fpage>e4792</fpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>Mengying</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Rui</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Louis</surname></string-name>, <string-name><given-names>A. D.</given-names> <surname>Katherine</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Moritz</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Yuyu</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Can</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Siyi</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Dong-hoon</surname></string-name>, <string-name><given-names>A. B.</given-names> <surname>Gary</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Robyn</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Yihong</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Marian</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Alfred</surname></string-name>, <string-name><given-names>S. F.</given-names> <surname>Eric</surname></string-name> and <string-name><given-names>L.</given-names> <surname>Ying</surname></string-name></person-group> (<year>2023</year>). <article-title>“HUWE1 Amplifies Ubiquitin Modifications to Broadly Stimulate Clearance of Proteins and Aggregates.”</article-title> <source>bioRxiv</source>:<elocation-id> 2023.2005.2030.542866</elocation-id>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mirdita</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Schutze</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Moriwaki</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Heo</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Ovchinnikov</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Steinegger</surname></string-name></person-group> (<year>2022</year>). “<article-title>ColabFold: making protein folding accessible to all</article-title>.” <source>Nat Methods</source> <volume>19</volume>(<issue>6</issue>): <fpage>679</fpage>–<lpage>682</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nair</surname>, <given-names>R. M.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Seenivasan</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>E. D.</given-names> <surname>Lowe</surname></string-name> and <string-name><given-names>S.</given-names> <surname>Lorenz</surname></string-name></person-group> (<year>2021</year>). “<article-title>Reconstitution and Structural Analysis of a HECT Ligase-Ubiquitin Complex via an Activity-Based Probe</article-title>.” <source>ACS Chem Biol</source> <volume>16</volume>(<issue>9</issue>): <fpage>1615</fpage>–<lpage>1621</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakatsukasa</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Sone</surname></string-name>, <string-name><given-names>D. H.</given-names> <surname>Alemayehu</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Okumura</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Kamura</surname></string-name></person-group> (<year>2018</year>). “<article-title>The HECT-type ubiquitin ligase Tom1 contributes to the turnover of Spo12, a component of the FEAR network, in G2/M phase</article-title>.” <source>FEBS Lett</source> <volume>592</volume>(<issue>10</issue>): <fpage>1716</fpage>–<lpage>1724</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Narain</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>P.</given-names> <surname>Bhandare</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Adhikari</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Backes</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Eilers</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Dolken</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Schlosser</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Erhard</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Baluapuri</surname></string-name> and <string-name><given-names>E.</given-names> <surname>Wolf</surname></string-name></person-group> (<year>2021</year>). “<article-title>Targeted protein degradation reveals a direct role of SPT6 in RNAPII elongation and termination</article-title>.” <source>Mol Cell</source> <volume>81</volume>(<issue>15</issue>): <fpage>3110</fpage>–<lpage>3127.</lpage> </mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pandya</surname>, <given-names>R. K.</given-names></string-name>, <string-name><given-names>J. R.</given-names> <surname>Partridge</surname></string-name>, <string-name><given-names>K. R.</given-names> <surname>Love</surname></string-name>, <string-name><given-names>T. U.</given-names> <surname>Schwartz</surname></string-name> and <string-name><given-names>H. L.</given-names> <surname>Ploegh</surname></string-name></person-group> (<year>2010</year>). “<article-title>A structural element within the HUWE1 HECT domain modulates self-ubiquitination and substrate ubiquitination activities</article-title>.” <source>J Biol Chem</source> <volume>285</volume>(<issue>8</issue>): <fpage>5664</fpage>–<lpage>5673</lpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pettersen</surname>, <given-names>E. F.</given-names></string-name>, <string-name><given-names>T. D.</given-names> <surname>Goddard</surname></string-name>, <string-name><given-names>C. C.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>G. S.</given-names> <surname>Couch</surname></string-name>, <string-name><given-names>D. M.</given-names> <surname>Greenblatt</surname></string-name>, <string-name><given-names>E. C.</given-names> <surname>Meng</surname></string-name> and <string-name><given-names>T. E.</given-names> <surname>Ferrin</surname></string-name></person-group> (<year>2004</year>). “<article-title>UCSF Chimera--a visualization system for exploratory research and analysis</article-title>.” <source>J Comput Chem</source> <volume>25</volume>(<issue>13</issue>): <fpage>1605</fpage>–<lpage>1612</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pillet</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Mendez-Godoy</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Murat</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Favre</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Stumpe</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Falquet</surname></string-name> and <string-name><given-names>D.</given-names> <surname>Kressler</surname></string-name></person-group> (<year>2022</year>). <article-title>“Dedicated chaperones coordinate co-translational regulation of ribosomal protein production with ribosome assembly to preserve proteostasis.”</article-title> <source>Elife</source> <volume>11</volume>: <elocation-id>e74255</elocation-id>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Punjani</surname>, <given-names>A.</given-names></string-name> and <string-name><given-names>D. J.</given-names> <surname>Fleet</surname></string-name></person-group> (<year>2021</year>). “<article-title>3D variability analysis: Resolving continuous flexibility and discrete heterogeneity from single particle cryo-EM</article-title>.” <source>J Struct Biol</source> <volume>213</volume>(<issue>2</issue>): <fpage>107702</fpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Punjani</surname>, <given-names>A.</given-names></string-name> and <string-name><given-names>D. J.</given-names> <surname>Fleet</surname></string-name></person-group> (<year>2023</year>). “<article-title>3DFlex: determining structure and motion of flexible proteins from cryo-EM</article-title>.” <source>Nat Methods</source> <volume>20</volume>(<issue>6</issue>): <fpage>860</fpage>–<lpage>870</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Punjani</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>J. L.</given-names> <surname>Rubinstein</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Fleet</surname></string-name> and <string-name><given-names>M. A.</given-names> <surname>Brubaker</surname></string-name></person-group> (<year>2017</year>). “<article-title>cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination</article-title>.” <source>Nat Methods</source> <volume>14</volume>(<issue>3</issue>): <fpage>290</fpage>–<lpage>296</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saleh</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Collart</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>Martens</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Genereaux</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Allard</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Cote</surname></string-name> and <string-name><given-names>C. J.</given-names> <surname>Brandl</surname></string-name></person-group> (<year>1998</year>). “<article-title>TOM1p, a yeast hect-domain protein which mediates transcriptional regulation through the ADA/SAGA coactivator complexes</article-title>.” <source>J Mol Biol</source> <volume>282</volume>(<issue>5</issue>): <fpage>933</fpage>–<lpage>946</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salvat</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Dastur</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Lyon</surname></string-name> and <string-name><given-names>J. M.</given-names> <surname>Huibregtse</surname></string-name></person-group> (<year>2004</year>). “<article-title>The -4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases</article-title>.” <source>J Biol Chem</source> <volume>279</volume>(<issue>18</issue>): <fpage>18935</fpage>–<lpage>18943</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sdano</surname>, <given-names>M. A.</given-names></string-name>, <string-name><given-names>J. M.</given-names> <surname>Fulcher</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Palani</surname></string-name>, <string-name><given-names>M. B.</given-names> <surname>Chandrasekharan</surname></string-name>, <string-name><given-names>T. J.</given-names> <surname>Parnell</surname></string-name>, <string-name><given-names>F. G.</given-names> <surname>Whitby</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name> and <string-name><given-names>C. P.</given-names> <surname>Hill</surname></string-name></person-group> (<year>2017</year>). <article-title>“A novel SH2 recognition mechanism recruits Spt6 to the doubly phosphorylated RNA polymerase II linker at sites of transcription.”</article-title> <source>Elife</source> <volume>6</volume>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname>, <given-names>R. K.</given-names></string-name>, <string-name><given-names>M. H.</given-names> <surname>Kabbaj</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Paik</surname></string-name> and <string-name><given-names>A.</given-names> <surname>Gunjan</surname></string-name></person-group> (<year>2009</year>). “<article-title>Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis</article-title>.” <source>Nat Cell Biol</source> <volume>11</volume>(<issue>8</issue>): <fpage>925</fpage>–<lpage>933</lpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Ng</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Nayak</surname></string-name> and <string-name><given-names>J.</given-names> <surname>Sivaraman</surname></string-name></person-group> (<year>2019</year>). “<article-title>Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities in vitro</article-title>.” <source>J Biol Chem</source> <volume>294</volume>(<issue>52</issue>): <fpage>19934</fpage>–<lpage>19949</lpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Solvie</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Baluapuri</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Uhl</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Fleischhauer</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Endres</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Papadopoulos</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Aziba</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Gaballa</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Mikicic</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Isaakova</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Giansanti</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Jansen</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Jungblut</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Klein</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Schülein-Völk</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Maric</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Doose</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Sauer</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Beli</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Rosenwald</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Dobbelstein</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Wolf</surname></string-name> and <string-name><given-names>M.</given-names> <surname>Eilers</surname></string-name></person-group> (<year>2022</year>). “<article-title>MYC multimers shield stalled replication forks from RNA polymerase</article-title>.” <source>Nature</source> <volume>612</volume>(<issue>7938</issue>): <fpage>148</fpage>–<lpage>155</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Storici</surname>, <given-names>F.</given-names></string-name>, <string-name><given-names>L. K.</given-names> <surname>Lewis</surname></string-name> and <string-name><given-names>M. A.</given-names> <surname>Resnick</surname></string-name></person-group> (<year>2001</year>). “<article-title>In vivo site-directed mutagenesis using oligonucleotides</article-title>.” <source>Nat Biotechnol</source> <volume>19</volume>(<issue>8</issue>): <fpage>773</fpage>–<lpage>776</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Su</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Cheng</surname></string-name> and <string-name><given-names>J.</given-names> <surname>Hou</surname></string-name></person-group> (<year>2019</year>). “<article-title>Meta-analysis of gene expression alterations and clinical significance of the HECT domain-containing ubiquitin ligase HUWE1 in cancer</article-title>.” <source>Oncol Lett</source> <volume>18</volume>(<issue>3</issue>): <fpage>2292</fpage>–<lpage>2303</lpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sung</surname>, <given-names>M. K.</given-names></string-name>, <string-name><given-names>T. R.</given-names> <surname>Porras-Yakushi</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Reitsma</surname></string-name>, <string-name><given-names>F. M.</given-names> <surname>Huber</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>Sweredoski</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Hoelz</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hess</surname></string-name> and <string-name><given-names>R. J.</given-names> <surname>Deshaies</surname></string-name></person-group> (<year>2016</year>). <article-title>“A conserved quality-control pathway that mediates degradation of unassembled ribosomal proteins.”</article-title> <source>Elife</source> <volume>5</volume>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tabb</surname>, <given-names>A. L.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Utsugi</surname></string-name>, <string-name><given-names>C. R.</given-names> <surname>Wooten-Kee</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Sasaki</surname></string-name>, <string-name><given-names>S. A.</given-names> <surname>Edling</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Gump</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Kikuchi</surname></string-name> and <string-name><given-names>S. R.</given-names> <surname>Ellis</surname></string-name></person-group> (<year>2001</year>). “<article-title>Genes encoding ribosomal proteins Rps0A/B of Saccharomyces cerevisiae interact with TOM1 mutants defective in ribosome synthesis</article-title>.” <source>Genetics</source> <volume>157</volume>(<issue>3</issue>): <fpage>1107</fpage>–<lpage>1116</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thompson</surname>, <given-names>J. W.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Nagel</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hoving</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Gerrits</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bauer</surname></string-name>, <string-name><given-names>J. R.</given-names> <surname>Thomas</surname></string-name>, <string-name><given-names>M. W.</given-names> <surname>Kirschner</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Schirle</surname></string-name> and <string-name><given-names>S. J.</given-names> <surname>Luchansky</surname></string-name></person-group> (<year>2014</year>). “<article-title>Quantitative Lys--Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1</article-title>.” <source>J Biol Chem</source> <volume>289</volume>(<issue>42</issue>): <fpage>28942</fpage>–<lpage>28955</lpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Utsugi</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Hirata</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Sekiguchi</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Sasaki</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Toh-e</surname></string-name> and <string-name><given-names>Y.</given-names> <surname>Kikuchi</surname></string-name></person-group> (<year>1999</year>). “<article-title>Yeast tom1 mutant exhibits pleiotropic defects in nuclear division, maintenance of nuclear structure and nucleocytoplasmic transport at high temperatures</article-title>.” <source>Gene</source> <volume>234</volume>(<issue>2</issue>): <fpage>285</fpage>–<lpage>295</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Verdecia</surname>, <given-names>M. A.</given-names></string-name>, <string-name><given-names>C. A.</given-names> <surname>Joazeiro</surname></string-name>, <string-name><given-names>N. J.</given-names> <surname>Wells</surname></string-name>, <string-name><given-names>J. L.</given-names> <surname>Ferrer</surname></string-name>, <string-name><given-names>M. E.</given-names> <surname>Bowman</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Hunter</surname></string-name> and <string-name><given-names>J. P.</given-names> <surname>Noel</surname></string-name></person-group> (<year>2003</year>). “<article-title>Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase</article-title>.” <source>Mol Cell</source> <volume>11</volume>(<issue>1</issue>): <fpage>249</fpage>–<lpage>259</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vos</surname>, <given-names>S. M.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Farnung</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Boehning</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Wigge</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Linden</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Urlaub</surname></string-name> and <string-name><given-names>P.</given-names> <surname>Cramer</surname></string-name></person-group> (<year>2018</year>). “<article-title>Structure of activated transcription complex Pol II-DSIF-PAF-SPT6</article-title>.” <source>Nature</source> <volume>560</volume>(<issue>7720</issue>): <fpage>607</fpage>–<lpage>612</lpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>P. P.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Byrum</surname></string-name>, <string-name><given-names>F. C.</given-names> <surname>Fowler</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Pa</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Tackett</surname></string-name> and <string-name><given-names>J. K.</given-names> <surname>Tyler</surname></string-name></person-group> (<year>2017</year>). “<article-title>Proteomic identification of histone post-translational modifications and proteins enriched at a DNA double-strand break</article-title>.” <source>Nucleic Acids Research</source> <volume>45</volume>(<issue>19</issue>): <fpage>10923</fpage>–<lpage>10940</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>Q.</given-names> <surname>Li</surname></string-name> and <string-name><given-names>X. Z.</given-names> <surname>Chen</surname></string-name></person-group> (<year>2007</year>). “<article-title>Detecting protein-protein interactions by Far western blotting</article-title>.” <source>Nat Protoc</source> <volume>2</volume>(<issue>12</issue>): <fpage>3278</fpage>–<lpage>3284</lpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xin</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Takahata</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Blanksma</surname></string-name>, <string-name><given-names>L.</given-names> <surname>McCullough</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Stillman</surname></string-name> and <string-name><given-names>T.</given-names> <surname>Formosa</surname></string-name></person-group> (<year>2009</year>). “<article-title>yFACT induces global accessibility of nucleosomal DNA without H2A-H2B displacement</article-title>.” <source>Mol Cell</source> <volume>35</volume>(<issue>3</issue>): <fpage>365</fpage>–<lpage>376</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>D. E.</given-names> <surname>Anderson</surname></string-name> and <string-name><given-names>Y.</given-names> <surname>Ye</surname></string-name></person-group> (<year>2016</year>). “<article-title>The HECT domain ubiquitin ligase HUWE1 targets unassembled soluble proteins for degradation</article-title>.” <source>Cell Discov</source> <volume>2</volume>: <fpage>16040</fpage>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>S. W.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Connelly</surname></string-name>, <string-name><given-names>S. N.</given-names> <surname>Porter</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Kodali</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Gan</surname></string-name>, <string-name><given-names>J. M.</given-names> <surname>Park</surname></string-name>, <string-name><given-names>K. F.</given-names> <surname>Tacer</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Tillman</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>S. M.</given-names> <surname>Pruett-Miller</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Li</surname></string-name> and <string-name><given-names>P. R.</given-names> <surname>Potts</surname></string-name></person-group> (<year>2020</year>). “<article-title>A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3’ End Processing Complex</article-title>.” <source>Mol Cell</source> <volume>77</volume>(<issue>6</issue>): <fpage>1206</fpage>–<lpage>1221.</lpage> </mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zumer</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>K. C.</given-names> <surname>Maier</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Farnung</surname></string-name>, <string-name><given-names>M. G.</given-names> <surname>Jaeger</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Rus</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Winter</surname></string-name> and <string-name><given-names>P.</given-names> <surname>Cramer</surname></string-name></person-group> (<year>2021</year>). “<article-title>Two distinct mechanisms of RNA polymerase II elongation stimulation in vivo</article-title>.” <source>Mol Cell</source> <volume>81</volume>(<issue>15</issue>): <fpage>3096</fpage>–<lpage>3109.</lpage> </mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101393.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dang</surname>
<given-names>Weiwei</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Baylor College of Medicine</institution>
</institution-wrap>
<city>Houston</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>useful</bold> manuscript presents findings on Tom1p's interaction with Spt6p and its role in chromatin dynamics, supported by structural analysis through CryoEM. The evidence for the conclusions is currently <bold>incomplete</bold>, lacking key experiments including continuation in vivo interaction and orthogonal binding assays (e.g., SPR, MST, ITC) to fully support the proposed mechanism. While the results are promising, further validation is needed to strengthen the evidence and improve the manuscript's overall cohesion.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101393.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this preprint, Madrigal et al present &quot;Tom1p ubiquitin ligase structure, interaction with Spt6p, and function in maintaining normal transcript levels and the stability of chromatin in promoters&quot; which describes the identification of Tom1p, a conserved ubiquitin ligase, as a potential binding partner for the transcription elongation/histone chaperone Spt6p, and reveal the Tom1p structure as determined by CryoEM. Tom1p is a homolog of human HUWE1, which has been implicated in decay for a variety of basic protein substrates such as ribosomal proteins and histones. Structure-function analyses identify regions required for Spt6p interaction, suggesting that the interaction with Spt6p is phosphorylation dependent, and for interactions with histones, the latter of which confers phenotypes in vivo when mutated, suggesting that the Tom1p acidic region is important for its function. What is less clear is the function or interaction with Spt6p. The manuscript speculates that Spt6p-Tom1p interactions may tune Tom1p localization, and it is shown that Tom1p is recruited to transcribed genes by chromatin IP. In addition, the Tom1p structure will be valuable to those trying to understand the mechanisms of this very large ubiquitin ligase. Here, structures of homologs from other organisms have already been described elsewhere, however, the authors here indicate some details potentially not previously visualized in other structures.</p>
<p>Strengths:</p>
<p>It has not previously been known that the Spt6p tSH2 had any additional targets. Interaction with a ubiquitin ligase already implicated in histone turnover given Spt6p's role as histone chaperone is interesting. A structure of Tom1p also provides insight into this very large, conserved protein and structure-function analysis in a model system is a good start towards mechanistic dissection.</p>
<p>Weaknesses:</p>
<p>Some aspects of the manuscript seem less cohesive in that there are two halves of the manuscript and both don't quite solidify insights into the Spt6p relationship to Tom1p or deepen our understanding of Tom1p mechanism extensively, though results are a great start on both sides of the paper. There are several points that are less clear in that it is not known if Spt6p interacts with Tom1p and in what context. The interaction surface of Spt6p able to interact with Tom1p is the identical tSH2 that would be predicted to be occupied by phosphorylated RNAPII when Spt6p is incorporated into the RNAPII elongation complex. This means how and when Spt6p might be available to interact with Tom1p is not clear. Previous work from the Hill and Formosa groups on the tSH2 domain and its RNAPII linker target have suggested that phenotypes of mutants in the two are similar, suggesting that their main function is to interact with each other. A simple test of examining Tom1p interaction with genes in the tSH2 mutant was not done. Additionally, the Spt6p interacting surface on Tom1p is not narrowed to a specific putatively phosphorylated residue that it might target. It remains possible that mutations in other regions of Tom1p affect potential phosphorylation of this target, and therefore it is possible that some mutations that alter Spt6p interaction could do so indirectly. Finally, the authors might consider additional models for their discussion where Spt6p potentially could function to deliver histones to Tom1p.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101393.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Madrigal et al identified Tom1, a E3 ubiquitin ligase previously known to be involved in ribosome biogenesis, as a protein that binds to terminal tandem Src-homology 2 (tSH2) domain of Spt6. They mapped this interaction to the acid region of Tom1, which is also known to interact with histones. Cells with tom1 mutants that cannot bind Spt6 did not show temperature sensitive phenotypes displaced for tom1 null mutant. Using ChIP assays, they showed that Tom1 is enriched at gene bodies of highly transcribed genes, and a loss of tom1 leads to reduced nucleosomal changes at gene promoters. Finally, they also solved the structures of Tom1 lacking the acidic region and found that Tom1p can adopt a compact a-solenoidal &quot;basket&quot; similar to the previously described structure of HUWE1. Overall, this is an interesting study and I have the following suggestions to improve the manuscript.</p>
<p>Major concerns:</p>
<p>(1) Promoter regions are in general nucleosome free. How does Tom1 mutant affect nucleosome-sized fragments at the promoter regions?</p>
<p>(2) While Tom1 antibodies may not specific, could the author perform Tom1 ChIP-seq in wild type and tom 1 null cells? This dataset may be more informative than tagged Tom1 that may not be functional.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101393.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors report a novel, direct interaction of Spt6p tSH2 domain to Tom1p. This extends the function of Spt6p from communication with factors associated with RNAPII transcription to processes of ubiquitination. Tom1p is known to ubiquitinate a large variety of substrates, but it is unknown how substrate recognition is done in a specific manner. The team identified a conserved central acidic region of Tom1p which is essential for in vivo functions and binds to histones and nucleosomes, as well as Spt6p. They further describe the Tom1p occupancy pattern on chromatin, assigning it a stabilizing effect on nucleosomes near promotors and a destabilizing effect on nucleosomes within the gene bodies. The authors were able to resolve two different conformational states of Tom1p which are likely connected to its activity, and possibly substrate selectivity.</p>
<p>Overall, the authors show that an intrinsically disordered region in Tom1p is important for substrate interaction and function of Tom1p. The protein is further involved in chromatin architecture and structural transitions control its activity.</p>
<p>Strengths:</p>
<p>By revealing the interaction of Spt6p and Tom1p, the authors discover a novel connection between transcriptional elongation and processes of ubiquitination.</p>
<p>
In recent years, disordered regions of MDa protein complexes have become a focus of research projects. The effects of disordered regions on protein localization and specificity of binding interactions have been discussed in great extent, including proteins that are involved in chromatin remodeling and transcription. Adding to these current efforts, the authors assign a function to a highly conserved disordered region of Tom1p in technically clean experiments. Furthermore, with their data, they pin down a specific functional region in Tom1p which is relevant for the previously observed temperature sensitivity caused by Tom1p deletion in yeast.</p>
<p>
The team performs a thorough and complete analysis of the cryo-EM structure and they nicely model the hinge motion and details of an open and closed conformation.</p>
<p>Weaknesses:</p>
<p>Despite the high number of interesting findings, there is little connection between the individual sections of the manuscript. For example, many experiments are not related to Spt6p binding although this protein is presented as a major actor in this manuscript during the introduction. Furthermore, the structural analysis is well done, but it is also not quite clear how structural rearrangements are connected to Spt6 binding or chromatin remodeling. Some experimental results lack novelty, as similar data has previously been presented for the human homolog.</p>
<p>To confirm the novel, direct binding interaction of Spt6p and Tom1p, no orthogonal binding assays (SPR, MST, ITC) have been performed to confirm the interaction. To me, this is insufficient, especially since the team has purified both proteins to high quality levels, or could use peptides to test the function of the relevant regions.</p>
<p>
Additionally, interaction of Tom1p with Spt6p in the context of transcription elongation is proposed. Yet it is not clear on the mechanistic level how this is regulated if Tom1p and Rpb1p bind in a competitive manner. How is Tom1p tethered to the elongation complex if not through Spt6p? In addition to WT vs. knockout, the authors should further perform the genetic analyses with the intΔ11 mutant. This way they might be able pin down which interactions on chromatin are mediated by Spt6 vs. by other factors and could strengthen the overall model involving Spt6P.</p>
<p>Although the authors try to describe a final model in the discussion, this section is not easy to follow and needs more explanation, ideally drawn as a Figure of the proposed mechanism.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101393.1.sa4</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Madrigal</surname>
<given-names>Jennifer</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8141-3194</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Schubert</surname>
<given-names>Heidi L</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1762-8390</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Sdano</surname>
<given-names>Matthew A</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6702-2755</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>McCullough</surname>
<given-names>Laura</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2206-6479</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Connell</surname>
<given-names>Zaily</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-8226-7412</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Formosa</surname>
<given-names>Tim</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8477-2483</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Hill</surname>
<given-names>Christopher P</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6796-7740</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>We thank the reviewers’ for their helpful comments.  We will make several minor edits to the text to improve clarity. Further experiments are beyond the scope of the current study.</p>
</body>
</sub-article>
</article>